<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="ppub"/></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS189197</article-id><article-id pub-id-type="doi">10.1101/2023.10.03.560720</article-id><article-id pub-id-type="archive">PPR736767</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Type I IFN signaling in the absence of IRGM1 promotes <italic>M. tuberculosis</italic> replication in immune cells by suppressing T cell responses</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Naik</surname><given-names>Sumanta K.</given-names></name><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>McNehlan</surname><given-names>Michael E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Mreyoud</surname><given-names>Yassin</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kinsella</surname><given-names>Rachel L.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Smirnov</surname><given-names>Asya</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chowdhury</surname><given-names>Chanchal Sur</given-names></name></contrib><contrib contrib-type="author"><name><surname>McKee</surname><given-names>Samuel R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dubey</surname><given-names>Neha</given-names></name></contrib><contrib contrib-type="author"><name><surname>Woodson</surname><given-names>Reilly</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kreamalmeyer</surname><given-names>Darren</given-names></name></contrib><contrib contrib-type="author"><name><surname>Stallings</surname><given-names>Christina L.</given-names></name><xref ref-type="corresp" rid="CR1">*</xref></contrib><aff id="A1">Department of Molecular Microbiology, Center for Women’s Infectious Disease Research, Washington University School of Medicine, St. Louis, MO 63110, USA</aff></contrib-group><author-notes><corresp id="CR1">
<label>*</label>Correspondence: <email>sknaik@wustl.edu</email> and <email>stallings@wustl.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>07</day><month>10</month><year>2023</year></pub-date><pub-date pub-type="preprint"><day>05</day><month>10</month><year>2023</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">CC BY-NC 4.0 International license</ext-link>.</license-p></license></permissions><abstract><p id="P1">Polymorphisms in the <italic>IRGM</italic> gene are associated with susceptibility to tuberculosis in humans. A murine ortholog of <italic>Irgm, Irgm1</italic>, is also essential for controlling <italic>Mycobacterium tuberculosis</italic> (Mtb) infection in mice. Multiple processes have been associated with IRGM1 activity that could impact the host response to Mtb infection, including roles in autophagy-mediated pathogen clearance and expansion of activated T cells. However, what IRGM1-mediated pathway is necessary to control Mtb infection <italic>in vivo</italic> and the mechanistic basis for this control remains unknown. We dissected the contribution of IRGM1 to immune control of Mtb pathogenesis <italic>in vivo</italic> and found that <italic>Irgm1</italic> deletion leads to higher levels of IRGM3-dependent type I interferon signaling. The increased type I interferon signaling precludes T cell expansion during Mtb infection. The absence of Mtb-specific T cell expansion in <italic>Irgm1<sup>-/-</sup></italic> mice results in uncontrolled Mtb infection in neutrophils and alveolar macrophages, which directly contributes to susceptibility to infection. Together, our studies reveal that IRGM1 is required to promote T cell-mediated control of Mtb infection in neutrophils, which is essential for the survival of Mtb-infected mice. These studies also uncover new ways type I interferon signaling can impact T<sub>H</sub>1 immune responses.</p></abstract><kwd-group><kwd>Mycobacterium tuberculosis</kwd><kwd>macrophage</kwd><kwd>neutrophil</kwd><kwd>IRGM1</kwd><kwd>IRGM3</kwd><kwd>inflammation</kwd><kwd>T cell</kwd><kwd>type I interferon</kwd><kwd>IFN-g</kwd><kwd>lung</kwd><kwd>lymph node</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P2"><italic>Mycobacterium tuberculosis</italic> (Mtb) infection is a leading cause of death world-wide. The COVID-19 pandemic has reversed years of global efforts to tackle the tuberculosis (TB) pandemic, where for the first time in over a decade, TB deaths have increased over the last year<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. The clinical outcomes of TB are driven by the immune response mounted in the host. Because of the pivotal role of the immune response in TB, there is a growing interest in developing immunotherapies that harness the immune response to control the infection, however, this will require a better understanding of the immune responses required to control Mtb infection. Interferon (IFN) inducible immunity-related GTPases (IRGs) play important roles in the host immune response to intracellular pathogens<sup><xref ref-type="bibr" rid="R2">2</xref></sup>, where a polymorphism in the <italic>IRGM</italic> gene that decreases its expression has been associated with Crohn’s disease and active TB disease in humans<sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref></sup>. Mice encode three IRGM orthologs, IRGM1, IRGM2, IRGM3, that have been shown to have non-redundant functions. In particular, <italic>Irgm1<sup>-/-</sup></italic> mice infected with Mtb succumb early with higher bacterial burdens and larger lesions of inflammation in their lungs<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R6">6</xref></sup>, supporting a requirement for IRGM1 expression for a protective immune response to Mtb. Deletion of <italic>Irgm3</italic> rescues the higher bacterial burdens and early susceptibility in <italic>Irgm1<sup>-/-</sup></italic> mice during Mtb infection<sup><xref ref-type="bibr" rid="R5">5</xref></sup>, indicating that a balance of IRGM1 and IRGM3 is required to control Mtb pathogenesis. However, the underlying mechanism for why IRGM1 is required in the presence of IRGM3 expression to control Mtb infection remains unknown.</p><p id="P3">Inter-regulatory roles for IRGM homologs have been implicated in multiple processes, where the most extensively studied has been the role for IRGM orthologs in autophagy. In particular, decreased expression of IRGM1 results in defects in autophagy in epithelial cells and phagocytes <italic>in vitro</italic><sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R7">7</xref>–<xref ref-type="bibr" rid="R9">9</xref></sup>. which can be reversed by deletion of <italic>Irgm3</italic><sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref></sup>. In initial studies, IRGM1 was shown to co-localize with Mtb in autophagosomes within infected macrophages and facilitate the trafficking of Mtb to lysosomes <italic>in vitro</italic><sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R14">14</xref></sup>, which supported an original model that IRGM1 controls Mtb replication by promoting autophagy-mediated clearance of the pathogen. However, more recently this was drawn into question by a report that IRGM1 does not colocalize with phagosomes containing <italic>Mycobacterium bovis</italic> BCG in IFN-γ-treated cells<sup><xref ref-type="bibr" rid="R15">15</xref></sup>. In addition, we have previously shown that autophagy is not required within infected myeloid cells to control Mtb replication <italic>in vivo</italic> in the mouse models used to study <italic>Irgm1</italic><sup><xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17">17</xref></sup>. Therefore, defects in autophagy-mediated targeting of Mtb to lysosomes within infected cells is unlikely to explain the susceptibility of <italic>Irgm1<sup>-/-</sup></italic> mice to Mtb.</p><p id="P4">More recently, studies investigating the role for <italic>Irgm1</italic> during mycobacterial infection showed that <italic>Irgm1<sup>-/-</sup></italic> mice are unable to control <italic>Mycobacterium avium</italic> replication and succumb to the infection earlier than wild-type (WT) controls due to IFN-γ-induced autophagic cell death of T cells following priming and activation<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. <italic>Irgm1</italic>-deficient T cells were able to rescue the susceptibility of <italic>RAG2<sup>-/-</sup></italic> mice to <italic>M. avium</italic> infection, suggesting that the defect in survival following activation was not T cell intrinsic<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. However, <italic>in vitro</italic> studies revealed that IRGM1-deficient T cells exhibit decreased survival and defective expansion following activation in the presence of IFN-γ, suggesting that there are T cell intrinsic roles for IRGM1 as well as roles for IRGM1 in other cells that contribute to survival of T cells following activation in the presence of IFN-γ<sup><xref ref-type="bibr" rid="R19">19</xref></sup>. In addition to the effects on T cells following activation, <italic>Irgm1<sup>-/-</sup></italic> mice also exhibit IFN-γ-dependent hematopoietic stem cell (HSC) hyperproliferation and defects in HSC differentiation during <italic>M. avium</italic> infection, which may also contribute to the lymphopenia<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R21">21</xref></sup>. Pulmonary Mtb infection of <italic>Irgm1<sup>-/-</sup></italic> mice was also accompanied by decreased cellularity and lower T cell numbers in the draining lymph node (dLN) compared to WT controls<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. Similar observations have been reported during infection with the intestinal pathogen <italic>Citrobacter rodentium,</italic> where <italic>Irgm1<sup>-/-</sup></italic> mice exhibit a defect in T<sub>H</sub>1 cell expansion and myeloid cell survival following infection<sup><xref ref-type="bibr" rid="R22">22</xref></sup>. The decreased T<sub>H</sub>1 cell expansion and myeloid cell survival following <italic>C. rodentium</italic> infection was attributed to increased apoptosis in the absence of IRGM1 expression. Macrophages from <italic>Irgm1<sup>-/-</sup></italic> mice infected with <italic>Salmonella typhimurium</italic> also exhibit impaired IFN-γ responses, including defects in adhesion, motility, and killing of the bacteria<sup><xref ref-type="bibr" rid="R23">23</xref></sup>. <italic>Irgm3</italic> deletion reverses the effects of <italic>Irgm1</italic> deletion on IFN-γ responses in HSCs<sup><xref ref-type="bibr" rid="R20">20</xref>,<xref ref-type="bibr" rid="R23">23</xref></sup>, but whether <italic>Irgm3</italic> deletion would reverse hypersensitivity to IFN-g in other cell types has yet to be determined.</p><p id="P5">These prior studies highlight multiple potential roles for IRGM1 that could affect control of Mtb infection, however, no specific role has been directly shown to contribute to the susceptibility. In this manuscript, we dissect the mechanistic basis for IRGM1-mediated protection against Mtb infection <italic>in vivo.</italic> We found that <italic>Irgm1</italic> deletion leads to higher levels of IRGM3-dependent type I IFN signaling in naïve mice. The increased type I IFN conditions an environment where following Mtb infection, dendritic cells (DCs) are less abundant in the lungs and dLN, and the T cell population is unable to expand following activation in the dLN. The absence of Mtb-specific T cell responses results in uncontrolled Mtb infection in neutrophils and alveolar macrophages (AMs) within the lung, which directly contributes to susceptibility to Mtb infection. Therefore, our data not only reveal the basis for IRGM1-mediated protection during Mtb infection <italic>in vivo</italic>, they also reveal a previously unknown consequence of increased type I IFN signaling on T<sub>H</sub>1 responses, which could in part explain the association of type I IFN with poor TB disease outcomes in humans and mice and could also apply to other infections requiring T<sub>H</sub>1 immunity for control.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Susceptibility of <italic>Irgm1<sup>-/-</sup></italic> mice to Mtb infection is associated with impaired T cell expansion in the dLN and defects in innate immune cells in the lung</title><p id="P6">To investigate the mechanistic basis for the requirement of IRGM1 in protection against Mtb infection, we used a mouse model of pulmonary Mtb infection. Following aerosol infection of a WT mouse, alveolar macrophages (AMs) phagocytose Mtb and traffic to the parenchyma, spreading the bacteria to other immune cells<sup><xref ref-type="bibr" rid="R24">24</xref>–<xref ref-type="bibr" rid="R26">26</xref></sup>. Monocyte-derived DCs transport Mtb antigen to the dLN at 8-9 days post infection (dpi) and facilitate priming, activation, and proliferation of Mtb-specific T cells<sup><xref ref-type="bibr" rid="R27">27</xref>–<xref ref-type="bibr" rid="R29">29</xref></sup>. Effector T cells then traffic to the lungs beginning at 18 dpi and activate the infected innate immune cells to suppress Mtb replication<sup><xref ref-type="bibr" rid="R30">30</xref></sup>, allowing for survival of a WT mouse for over 150 days. Infection of <italic>Irgm1<sup>-/-</sup></italic> mice with an Mtb strain that constitutively expresses GFP<sup><xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R32">32</xref></sup> (Mtb-GFP) results in early susceptibility (median survival of 41 days) (<xref ref-type="fig" rid="F1">Fig. 1A</xref>) and increased lung burden at 21 dpi (<xref ref-type="fig" rid="F1">Fig. 1B</xref>), similar to as previously reported<sup><xref ref-type="bibr" rid="R5">5</xref>,<xref ref-type="bibr" rid="R6">6</xref></sup>. Consistent with prior studies<sup><xref ref-type="bibr" rid="R19">19</xref></sup>, we also observed a defect in T cell expansion in the dLN of Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice, as evidenced by smaller lymph nodes size (<xref ref-type="fig" rid="F1">Fig. 1C</xref>) and decreased T cell numbers in the dLN at 21 dpi (<xref ref-type="fig" rid="F1">Fig. 1D</xref>). The lower numbers of T cells were associated with a lower number of activated CD4<sup>+</sup> T cells (CD44<sup>+</sup>CD62L<sup>-</sup>) in the dLN (<xref ref-type="fig" rid="F1">Fig. 1E</xref>). We also observed lower numbers of DCs in the dLN of <italic>Irgm1<sup>-/-</sup></italic> mice compared to controls at 21 dpi (<xref ref-type="fig" rid="F1">Fig. 1F</xref>), which could contribute to the absence of T cell expansion following infection. In addition, we monitored T cell viability using the Zombie Viability Dye (BioLegend) and observed decreased viability in activated CD4<sup>+</sup> T cells in the dLN of <italic>Irgm1<sup>-/-</sup></italic> mice compared to controls at 21 dpi (<xref ref-type="fig" rid="F1">Fig. 1G</xref>), which supports the prior model that IRGM1 is required for T cell survival following activation.</p><p id="P7">To determine how immune responses in the lung were affected by the defective dLN responses in <italic>Irgm1</italic><sup>-/-</sup> mice during Mtb infection, we performed flow cytometry analysis of immune cell populations in the lungs at 21 dpi. We observed decreased numbers of activated CD4<sup>+</sup> T cells in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice compared to WT mice at 21 dpi (<xref ref-type="fig" rid="F1">Fig. 1H</xref>), which is likely a result of the lack of T cell expansion in the dLN of Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="F1">Fig. 1C-E</xref>). In addition, the numbers of non-alveolar macrophages (includes interstitial macrophages and recruited macrophages) and DCs, which comprise the primary CCR2<sup>+</sup> cells that traffic to the dLN to present Mtb antigen<sup><xref ref-type="bibr" rid="R33">33</xref></sup>, were lower in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice compared to WT mice at 21 dpi (<xref ref-type="fig" rid="F1">Fig. 1I</xref>). In contrast, the numbers of neutrophils and AMs were higher in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice compared to WT mice at 21 dpi (<xref ref-type="fig" rid="F1">Fig. 1J</xref>). The differences in cell populations in the lungs of <italic>Irgm1</italic><sup>-/-</sup> mice compared to WT mice were infection-dependent, as there were no significant differences in naïve uninfected mice (<xref ref-type="supplementary-material" rid="SD2">Fig. S1</xref>). Analysis of Mtb burden in the different innate immune cell populations revealed a higher number of infected neutrophils and AMs, two cell types associated with poor control of Mtb replication<sup><xref ref-type="bibr" rid="R24">24</xref>,<xref ref-type="bibr" rid="R25">25</xref>,<xref ref-type="bibr" rid="R34">34</xref>,<xref ref-type="bibr" rid="R35">35</xref></sup>, in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice compared to WT mice (<xref ref-type="fig" rid="F1">Fig. 1K-M</xref>). In addition, there was increased Mtb burden per neutrophil (based on Mtb-GFP mean fluorescence intensity (MFI)) at 21dpi in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice compared to WT (<xref ref-type="fig" rid="F1">Fig. 1K, L</xref>). We were unable to reliably compare the Mtb burden in AMs because there were too few infected AMs in WT mice at 21 dpi. The increased numbers of Mtb-infected neutrophils and AMs at 21 dpi likely contribute to the higher Mtb burdens in the <italic>Irgm1<sup>-/-</sup></italic> lungs at this time point.</p><p id="P8">To further evaluate inflammatory responses in <italic>Irgm1<sup>-/-</sup></italic> mice during Mtb infection, we measured chemokine and cytokine levels in the lungs at 21 dpi using a cytokine bead array (Bio-Rad). The levels of IFN-γ, IL-12(p40), and RANTES were all lower at 21 dpi in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice compared to WT mice (<xref ref-type="fig" rid="F1">Fig. 1N</xref>), consistent with the defect in T cell responses. In contrast, the lungs of Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice contained significantly higher levels of IL-6, KC, MCP-1, and MIP-1α (<xref ref-type="fig" rid="F1">Fig. 1O</xref>), all of which are associated with neutrophil inflammatory responses<sup><xref ref-type="bibr" rid="R36">36</xref>–<xref ref-type="bibr" rid="R39">39</xref></sup>. Together, the cytokine profiling data supports the observations of decreased activated CD4<sup>+</sup> T cells and increased innate immune cell infection in the lungs of Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice.</p></sec><sec id="S4"><title>Adoptive transfer of activated Mtb-specific CD4<sup>+</sup> T cell rescues control of Mtb infection in innate immune cells and allows for survival of <italic>Irgm1<sup>-/-</sup></italic> mice</title><p id="P9">The defect in T cell expansion in the dLN and resulting absence of activated T cells in the lungs of Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice was accompanied by increased numbers and infection of neutrophils and AMs in the lungs at 21 dpi. We, therefore, investigated whether restoring Mtb-specific T cell responses in <italic>Irgm1<sup>-/-</sup></italic> mice could rescue control of Mtb infection. To bypass the need for antigen presentation and T cell expansion <italic>in vivo,</italic> we adoptively transferred Mtb ESAT-6 specific CD4<sup>+</sup> T cells that had been isolated from C7 TCR transgenic mice<sup><xref ref-type="bibr" rid="R40">40</xref></sup> and activated <italic>in vitro</italic> by incubating with irradiated splenocytes, ESAT-6 peptide, α-IL-4, IL-12, and IL-2 (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). <italic>In vitro</italic> activation of the C7 CD4<sup>+</sup> T cells was confirmed by monitoring the expression of T-bet by flow cytometry (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). We transferred 2.5 million activated C7 CD4<sup>+</sup> T cells into each WT and <italic>Irgm1<sup>-/-</sup></italic> mouse one day prior to Mtb infection and monitored immune cell infiltrate in the lungs at 21 dpi. The C7 cells express Thy1.1 and, thus, can be distinguished from the recipient mouse cells by flow cytometry (<xref ref-type="supplementary-material" rid="SD2">Fig. S5B</xref>). <italic>Irgm1<sup>-/-</sup></italic> mice accumulated a similar number of total C7 CD4<sup>+</sup> T cells in the lung as WT mice at 21dpi (<xref ref-type="fig" rid="F2">Fig. 2C</xref>), demonstrating that <italic>Irgm1<sup>-/-</sup></italic> mice were able to recruit activated Mtb-specific CD4<sup>+</sup> T cells to the lung. Adoptive transfer of activated Mtb-specific C7 Thy1.1<sup>+</sup> CD4<sup>+</sup> T had no effect on the numbers of recipient-derived Thy1.1<sup>-</sup> CD4<sup>+</sup> T cells or activated Thy1.1<sup>-</sup> CD4<sup>+</sup> T cells in the lungs and dLN of <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi (<xref ref-type="supplementary-material" rid="SD2">Fig. S2A and S2B</xref>).</p><p id="P10">The numbers of DCs remained low in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi following transfer of activated Mtb-specific CD4<sup>+</sup> T cells (<xref ref-type="fig" rid="F2">Fig. 2D</xref>) and although the number of non-alveolar macrophages were not significantly lower in <italic>Irgm1</italic><sup>-/-</sup> mice compared to WT in these experiments, they remained unchanged in abundance following transfer of activated Mtb-specific CD4<sup>+</sup> T cells (<xref ref-type="fig" rid="F2">Fig. 2E</xref>). These data suggest that T cell-independent processes contribute to the abundance of antigen-presenting cells in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice. In contrast, transfer of activated Mtb-specific CD4<sup>+</sup> T cells decreased the numbers of neutrophils and AMs in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi (<xref ref-type="fig" rid="F2">Fig. 2F, G</xref>), demonstrating that the presence of activated T cells is able to suppress the accumulation of these cell types in <italic>Irgm1<sup>-/-</sup></italic> mice. Transfer of activated Mtb-specific CD4<sup>+</sup> T cells also significantly reduced the number of Mtb-infected neutrophils and AMs in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi (<xref ref-type="fig" rid="F2">Fig. 2H</xref>) as well as decreased the Mtb burden per neutrophil (<xref ref-type="fig" rid="F2">Fig. 2I</xref>). The improved control of Mtb infection in neutrophils and AMs following transfer of activated Mtb-specific CD4<sup>+</sup> T cells corresponded to decreased Mtb burdens in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi (<xref ref-type="fig" rid="F2">Fig. 2J</xref>). We also monitored the survival of WT and <italic>Irgm1<sup>-/-</sup></italic> mice that received activated Mtb-specific CD4<sup>+</sup> T cells or PBS control and found that adoptive transfer of activated Mtb-specific CD4<sup>+</sup> T cells significantly extended the survival in <italic>Irgm1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="F2">Fig. 2K</xref>), demonstrating that T cell-mediated control of Mtb infection in neutrophils and AMs is sufficient to rescue the susceptibility of <italic>Irgm1<sup>-/-</sup></italic> mice. Together these data indicate that IRGM1 expression is required for survival following Mtb infection in mice due to its role in supporting Mtb-specific T<sub>H</sub>1 responses that promote control of Mtb infection of AMs and neutrophils.</p></sec><sec id="S5"><title>Neutrophil depletion extends the survival of <italic>Irgm1<sup>-/-</sup></italic> mice during Mtb infection</title><p id="P11">The extension in survival of Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice following adoptive transfer of activated Mtb-specific CD4<sup>+</sup> T cells was associated with decreased numbers of Mtb-infected neutrophils in the lungs at 21 dpi (<xref ref-type="fig" rid="F2">Fig. 2H, I</xref>). Excessive neutrophil recruitment and infection is associated with Mtb replication, tissue damage, and progression of Mtb disease in mice and humans<sup><xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R41">41</xref>–<xref ref-type="bibr" rid="R47">47</xref></sup>. If the critical role for T<sub>H</sub>1 responses that is lost in <italic>Irgm1<sup>-/-</sup></italic> mice during Mtb infection is control of Mtb infection and replication in neutrophils, then depletion of neutrophils might prolong survival of Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice. To directly test this possibility, we administered a neutrophil-depleting αLy6G (clone 1A8) antibody or isotype control antibody to WT and <italic>Irgm1<sup>-/-</sup></italic> mice beginning on 10 dpi with repeated injections every other day until 34 dpi (<xref ref-type="supplementary-material" rid="SD2">Fig. S3A</xref>) and monitored survival over time. Transiently depleting neutrophils in Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice from 10-34 dpi extended their median survival time from 43 dpi for IgG-treated <italic>Irgm1<sup>-/-</sup></italic> mice to 71 dpi for α-Ly6G-treated <italic>Irgm1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="F3">Fig. 3A</xref>), indicating that neutrophils directly contribute to the susceptibility of <italic>Irgm1<sup>-/-</sup></italic> mice to Mtb.</p><p id="P12">We monitored the effects of neutrophil depletion on immune cell infiltrate and Mtb burden at 21 dpi to identify the changes associated with the extended survival. We confirmed the efficient depletion of Gr1<sup>hi</sup> neutrophils (Ly6C<sup>lo</sup>) with αLy6G antibody treatment in the lungs of WT and <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi (<xref ref-type="fig" rid="F3">Fig. 3B, C</xref>), however, we also noted the persistence of a Gr1 intermediate (Gr1<sup>int</sup>) population that was resistant to depletion with the αLy6G antibody (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). The Gr1<sup>int</sup> population had two distinct populations of cells that either expressed high or low levels of Ly6C (Ly6C<sup>hi</sup> or Ly6C<sup>lo</sup>) on the cell surface (<xref ref-type="supplementary-material" rid="SD2">Fig. S3B</xref>) where the Ly6C<sup>hi</sup> cells are likely inflammatory monocytes and the Ly6C<sup>lo</sup> cells are likely non-classical monocytes or granulocytes, based on prior publications<sup><xref ref-type="bibr" rid="R48">48</xref>–<xref ref-type="bibr" rid="R50">50</xref></sup>. To separate the Ly6C<sup>lo</sup> non-classical monocyte and granulocyte populations, we gated the Ly6C<sup>lo</sup> cells based on surface expression of the monocyte/macrophage marker MERTK<sup><xref ref-type="bibr" rid="R51">51</xref></sup> (<xref ref-type="supplementary-material" rid="SD2">Fig. S3B</xref>). Administration of αLy6G antibody decreased the number of MERTK<sup>+</sup> Ly6C<sup>lo</sup> GR1<sup>int</sup> cells in the lungs of both WT and <italic>Irgm1<sup>-/-</sup></italic> mice compared to the IgG controls, whereas, the Ly6C<sup>hi</sup> Gr1<sup>int</sup> and MERTK<sup>-</sup> Ly6C<sup>lo</sup> Gr1<sup>int</sup> cells remained unchanged following αLy6G treatment (<xref ref-type="supplementary-material" rid="SD2">Fig. S3C-S3E</xref>). There were no significant differences in the numbers of any of the Gr1<sup>int</sup> cell populations between WT and <italic>Irgm1<sup>-/-</sup></italic> mice regardless of IgG or αLy6G treatment (<xref ref-type="supplementary-material" rid="SD2">Fig. S3C-E</xref>). Administration of αLy6G antibody decreased the number of Mtb infected Gr1<sup>hi</sup> neutrophils in the lungs of <italic>Irgm<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="F3">Fig. 3D</xref>) but did not change the numbers of Mtb-infected Gr1<sup>int</sup> cells (<xref ref-type="supplementary-material" rid="SD2">Fig. S3F-H</xref>). However, administration of αLy6G antibody resulted in the Mtb burden per cell for each Gr1<sup>int</sup> population being significantly higher in <italic>Irgm1<sup>-/-</sup></italic> mice compared to WT (<xref ref-type="fig" rid="F3">Fig. 3E-G</xref>). αLy6G antibody treatment in Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice also resulted in a trend of lower numbers of AMs and infected AMs, however, none of the differences for this population were statistically significant in these experiments (<xref ref-type="fig" rid="F3">Fig. 3H, I</xref>). αLy6G treatment did not rescue the lower numbers of DCs or non-alveolar macrophages in <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi (<xref ref-type="fig" rid="F3">Fig. 3J, K</xref>), indicating that these lower numbers of these cell types occurs independently of the higher numbers of Gr1<sup>hi</sup> neutrophils. Despite the increased survival of Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice following Gr1<sup>hi</sup> neutrophil depletion, the lung Mtb burdens remained high (<xref ref-type="fig" rid="F3">Fig. 3L</xref> and <xref ref-type="supplementary-material" rid="SD2">Fig. S3I</xref>), which was likely due to the maintained high levels of Mtb infection in the Gr1<sup>int</sup> cells.</p><p id="P13">Since transfer of activated Mtb-specific CD4<sup>+</sup> T cells was sufficient to promote control of Mtb infection in neutrophils, we analyzed CD4<sup>+</sup> T cell numbers at 21 dpi following αLy6G antibody treatment to determine if the T cell abundance remained low in <italic>Irgm1<sup>-/-</sup></italic> mice and this accounted for the high levels of Mtb infection in Gr1<sup>int</sup> cells. Indeed, αLy6G antibody treatment did not alter CD4<sup>+</sup> T cell numbers or activation in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi (<xref ref-type="fig" rid="F3">Fig. 3M</xref>), likely accounting for the continued high level of Gr1<sup>int</sup> cell infection in αLy6G treated <italic>Irgm1<sup>-/-</sup></italic> mice. Together these data indicate that neutrophils contribute to the susceptibility of <italic>Irgm1<sup>-/-</sup></italic> mice to Mtb infection, and their contribution is downstream of defects in CD4<sup>+</sup> T cell expansion in Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice.</p></sec><sec id="S6"><title>Increased type I IFN signaling in <italic>Irgm1<sup>-/-</sup></italic> mice causes defects in T cell expansion and susceptibility during Mtb infection</title><p id="P14">To investigate what pathways are regulated by IRGM1 that could be contributing to control of Mtb pathogenesis, we performed bulk RNA sequencing (RNAseq) analysis on total lung from WT and <italic>Irgm1<sup>-/-</sup></italic> mice at 21dpi. There were 2372 differentially expressed genes (p<sub>adj.</sub> ≤ 0.05), out of which 1072 were downregulated (<xref ref-type="supplementary-material" rid="SD3">Table S1</xref>) and 1300 were upregulated (<xref ref-type="supplementary-material" rid="SD4">Table S2</xref>), in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice compared to WT at 21 dpi. We determined the pathways enriched for genes that were significantly upregulated in the absence of <italic>Irgm1</italic> by inputting the list of significantly upregulated genes into EnrichR and querying the GO Biological Process-2021 gene set database<sup><xref ref-type="bibr" rid="R52">52</xref>,<xref ref-type="bibr" rid="R53">53</xref></sup>. The top 10 pathways that were significantly positively enriched in <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi were all related to IFN signaling and the top 7 out of 10 pathways were specifically related to type I IFN (<xref ref-type="fig" rid="F4">Fig. 4A</xref>). In addition, the genes within the “Cellular Response to Type I Interferon” GO pathway (GO:0071357) were amongst the highest upregulated genes in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi (<xref ref-type="supplementary-material" rid="SD2">Fig. S4A</xref>). We confirmed the upregulation of <italic>Ifnb1</italic> (gene for IFN-β) and several IFN stimulated genes (ISGs) in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi by quantitative real-time PCR (qRT-PCR) (<xref ref-type="fig" rid="F4">Fig. 4B</xref>). Previous reports have shown that the lungs of naïve <italic>Irgm1<sup>-/-</sup></italic> mice exhibit elevated expression of type I IFNs and ISGs and this improved host survival during viral infections<sup><xref ref-type="bibr" rid="R54">54</xref>–<xref ref-type="bibr" rid="R56">56</xref></sup>. We also observed increased ISG expression in the lungs of naïve <italic>Irgm1<sup>-/-</sup></italic> mice compared to WT controls by RNAseq and qRT-PCR, supporting that type I IFN signaling was elevated in <italic>Irgm1<sup>-/-</sup></italic> mice even before Mtb infection (<xref ref-type="supplementary-material" rid="SD3">Table S3</xref> and <xref ref-type="supplementary-material" rid="SD2">Fig. S4B</xref>). Type I IFN has been associated with poor control of Mtb infection in humans and mice<sup><xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R57">57</xref>–<xref ref-type="bibr" rid="R60">60</xref></sup>, although the mechanistic basis for how type I IFN signaling interferes with control of Mtb remains unknown. In addition, deletion of the gene encoding the type I IFN receptor, <italic>Ifnar1,</italic> in <italic>Irgm1<sup>-/-</sup></italic> mice rescues their susceptibility to Mtb infection through 150 dpi (<xref ref-type="fig" rid="F4">Fig. 4C</xref>)<sup><xref ref-type="bibr" rid="R61">61</xref></sup>, indicating that increased type I IFN signaling contributes to the susceptibility of <italic>Irgm1<sup>-/-</sup></italic> mice to Mtb.</p><p id="P15">To identify correlates of protection when type I IFN signaling is blocked in <italic>Irgm1<sup>-/-</sup></italic> mice, we compared the immune cell composition and Mtb burdens in WT, <italic>Irgm1<sup>-/-</sup>, Irgm1<sup>-/-</sup>/Ifnar1<sup>-/-</sup>,</italic> and <italic>Ifnar1<sup>-/-</sup></italic> mice at 21 dpi. When we analyzed the dLN at 21 dpi, we found that, despite the complete rescue in survival, the <italic>Irgm1<sup>-/-</sup>/Ifnar1<sup>-/-</sup></italic> mice still had smaller dLN than WT mice at 21 dpi (<xref ref-type="fig" rid="F4">Fig. 4D</xref>), where ablating type I IFN signaling only intermediately increased the numbers of CD4<sup>+</sup> T cells, activated CD4<sup>+</sup> T cells, and DCs in the dLN (<xref ref-type="fig" rid="F4">Fig. 4E</xref>). However, ablating type I IFN signaling increased the abundance of CD4<sup>+</sup> T cells and activated CD4<sup>+</sup> T cells in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice to numbers even higher than in WT mice (<xref ref-type="fig" rid="F4">Fig. 4F</xref>). The restored T cell responses in the lungs of <italic>Irgm1<sup>-/-</sup></italic> mice when <italic>Ifnar1</italic> was deleted was associated with decreased AMs (<xref ref-type="fig" rid="F4">Fig. 4G</xref>), increased DCs (<xref ref-type="fig" rid="F4">Fig. 4H</xref>), and increased nonalveolar macs (<xref ref-type="fig" rid="F4">Fig. 4I</xref>). Deletion of <italic>Ifnar1</italic> in <italic>Irgm1<sup>-/-</sup></italic> mice also resulted in lower numbers of Mtb-infected neutrophils and lower burdens of Mtb per neutrophil, without affecting the total number of neutrophils in the lungs (<xref ref-type="fig" rid="F4">Fig. 4J, K</xref>). Blocking type I IFN signaling in <italic>Irgm1<sup>-/-</sup></italic> mice similarly led to fewer Mtb infected AMs in the lung (<xref ref-type="fig" rid="F4">Fig. 4L</xref>). The decreased infection of neutrophils and AMs correlated with decreased Mtb burden in the lungs of <italic>Irgm1<sup>-/-</sup>/Ifnar1<sup>-/-</sup></italic> mice compared to the <italic>Irgm1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="F4">Fig. 4M</xref>). Therefore, loss of type I IFN signaling reversed most phenotypes in the lungs of Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice.</p><p id="P16">These studies indicate that the defective lung T<sub>H</sub>1 responses and increased neutrophil infection are downstream of the enhanced type I IFN signaling in Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice. To directly test this, we analyzed ISG expression in the lungs of WT and <italic>Irgm1<sup>-/-</sup></italic> mice at 21 dpi following transfer of activated Mtb-specific CD4<sup>+</sup> T cells or neutrophil depletion (<xref ref-type="fig" rid="F2">Fig. 2A</xref> and <xref ref-type="supplementary-material" rid="SD2">Fig. S3A</xref>). Despite the improved survival following transfer of activated Mtb-specific CD4<sup>+</sup> T cells (<xref ref-type="fig" rid="F2">Fig. 2K</xref>) or neutrophil depletion (<xref ref-type="fig" rid="F3">Fig. 3A</xref>), ISG expression remained high in the lungs of Mtb-infected <italic>Irgm1<sup>-/-</sup></italic> mice (<xref ref-type="supplementary-material" rid="SD2">Fig. S4C, D</xref>). Therefore, loss of T cell expansion and increased neutrophil infection were consequences, but not drivers, of the higher levels of type I IFN in <italic>Irgm1<sup>-/-</sup></italic> mice during Mtb infection.</p></sec><sec id="S7"><title>Increased type I IFN signaling in <italic>Irgm1<sup>-/-</sup></italic> mice during Mtb infection is dependent on IRGM3 expression</title><p id="P17">Deletion of <italic>Irgm3</italic> in <italic>Irgm1<sup>-/-</sup></italic> mice rescues the higher bacterial burdens and early susceptibility during Mtb infection<sup><xref ref-type="bibr" rid="R5">5</xref></sup> (<xref ref-type="fig" rid="F5">Fig. 5A, B</xref>), but the mechanistic basis of the rescue is unknown. IRGM1 has been shown to maintain mitochondrial quality control and suppress mitochondrial DNA-induced type I IFN production in the presence of IRGM3 expression in fibroblasts and macrophages<sup><xref ref-type="bibr" rid="R62">62</xref>,<xref ref-type="bibr" rid="R63">63</xref></sup>. As such, deletion of <italic>Irgm1</italic> in macrophages and fibroblasts leads to increased production of type I IFN, which is reversed if <italic>Irgm3</italic> is also deleted<sup><xref ref-type="bibr" rid="R62">62</xref></sup>. Therefore, we investigated whether the increased type I IFN signaling observed in <italic>Irgm1<sup>-/-</sup></italic> mice during Mtb infection was dependent on IRGM3 expression by infecting <italic>Irgm1<sup>-/-</sup>/Irgm3<sup>-/-</sup></italic> mice and measuring ISG expression in the lungs at 21 dpi. We observed a significant decrease in the expression of ISGs in the lungs of <italic>Irgm1<sup>-/-</sup>/Irgm3<sup>-/-</sup></italic> mice compared to the <italic>Irgm1<sup>-/-</sup></italic> mice (<xref ref-type="fig" rid="F5">Fig. 5C</xref>), indicating that indeed the increased type I IFN in <italic>Irgm1<sup>-/-</sup></italic> mice is dependent on IRGM3 expression. Similar to as observed when <italic>Ifnar1</italic> was deleted, the decreased type I IFN signaling in the <italic>Irgm1<sup>-/-</sup>/Irgm3<sup>-/-</sup></italic> mice was associated with increased numbers of activated CD4<sup>+</sup> activated T cells in the dLN (<xref ref-type="fig" rid="F5">Fig. 5D</xref>) and lungs (<xref ref-type="fig" rid="F5">Fig. 5E</xref>), increased DC numbers in the dLN (<xref ref-type="fig" rid="F5">Fig. 5F</xref>) and lung (<xref ref-type="fig" rid="F5">Fig. 5G</xref>), and decreased infection of neutrophils (<xref ref-type="fig" rid="F5">Fig. 5H</xref>) and AMs (<xref ref-type="fig" rid="F5">Fig. 5I</xref>). Therefore, the data suggest that IRGM3-induced type I interferon-mediated immunodeficiency in the absence of <italic>Irgm1</italic> results in susceptibility to Mtb infection in mice.</p></sec></sec><sec id="S8" sec-type="discussion"><title>Discussion</title><p id="P18">In this manuscript, we uncover the biological basis for how IRGM1 promotes control of Mtb infection. A role for IRGM1 in a protective host response to Mtb infection was identified over two decades ago<sup><xref ref-type="bibr" rid="R6">6</xref></sup> and initially the focus was on IRGM1 facilitating targeting of Mtb to lysosomes through the process of autophagy<sup><xref ref-type="bibr" rid="R6">6</xref>,<xref ref-type="bibr" rid="R12">12</xref>–<xref ref-type="bibr" rid="R14">14</xref></sup>. However, this model was drawn into question following reports that IRGM1 did not colocalize with mycobacteria in IFN-γ-treated cells<sup><xref ref-type="bibr" rid="R15">15</xref></sup> and the discovery that autophagy was not required to control Mtb replication in macrophages during infection of mice <italic>in vivo</italic><sup><xref ref-type="bibr" rid="R16">16</xref>,<xref ref-type="bibr" rid="R17">17</xref></sup>. More recent work has associated the requirement for IRGM1 during Mtb infection with IRGM3 activity<sup><xref ref-type="bibr" rid="R5">5</xref></sup>, type I IFN signaling<sup><xref ref-type="bibr" rid="R61">61</xref></sup>, and T<sub>H</sub>1 responses<sup><xref ref-type="bibr" rid="R18">18</xref></sup>, however, it remained unknown how these pathways intersected to impact IRGM1-mediated control of Mtb infection. Based on our data, we propose a model (<xref ref-type="fig" rid="F6">Fig. 6</xref>) wherein IRGM1 is required to suppress IRGM3-mediated induction of type I IFN in naïve mice. The higher levels of type I IFN in the absence of IRGM1 condition the environment of the mouse so that following infection, Mtb-specific T cells fail to expand and antigen presenting cells, such as DCs, decrease in numbers. The absence of T<sub>H</sub>1 responses allows for uncontrolled Mtb infection and replication in neutrophils and AMs, which directly contributes to the increased susceptibility of <italic>Irgm1<sup>-/-</sup></italic> mice to Mtb infection. These studies identify the mechanistic link between IRGM1, IRGM3, type I IFN, and T<sub>H</sub>1 responses during Mtb infection, while also revealing new roles for type I IFN signaling in suppressing the DC accumulation and T<sub>H</sub>1 responses in the lungs that are critical for promoting control of Mtb replication in neutrophils.</p><p id="P19">Type I IFN is associated with poor control of Mtb infection in humans and mice<sup><xref ref-type="bibr" rid="R43">43</xref>,<xref ref-type="bibr" rid="R47">47</xref>,<xref ref-type="bibr" rid="R58">58</xref>–<xref ref-type="bibr" rid="R60">60</xref></sup>, however, it remains unknown the mechanisms by which type I IFN could be suppressing control of Mtb. Given that the susceptibility of <italic>Irgm1<sup>-/-</sup></italic> mice to Mtb infection is dependent on type I IFN signaling, better understanding of the pathways driving the susceptibility of these mice could shed light on how more generally type I IFN impacts protective immune responses to Mtb. In addition, there are multiple features of the <italic>Irgm1<sup>-/-</sup></italic> mice that bear similarity to STING gain-of-function mutants, which also exhibit constitutively high levels of type I signaling<sup><xref ref-type="bibr" rid="R64">64</xref>–<xref ref-type="bibr" rid="R66">66</xref></sup>. Mice with STING gain-of-function mutations develop T cell-dependent lung disease<sup><xref ref-type="bibr" rid="R67">67</xref></sup> and also lack lymph nodes, which is attributed to decreased numbers of innate lymphoid cells, including lymphoid tissue inducer cells, in STING gain-of-function mice<sup><xref ref-type="bibr" rid="R68">68</xref></sup>. Although, it is not known why there are defects in the numbers of lymphoid tissue inducer cells in STING gain-of-function mice, it is possible that the mechanism is shared with <italic>Irgm1</italic><sup>-/-</sup> mice and may be related to heightened type I IFN signaling in both of these mouse backgrounds. In addition, IFN-γ signaling is required for the lymph node development and T cell defects in STING gain-of-function mice<sup><xref ref-type="bibr" rid="R69">69</xref></sup>, similar to our model that elevated type I IFN signaling in <italic>Irgm1</italic><sup>-/-</sup> mice sensitizes the CD4<sup>+</sup> T cells to IFN-γ-dependent cell death, where IFN-γ is produced upon activation during Mtb infection. One could also imagine that the type I IFN conditioning of the tissue that occurs in naïve <italic>Irgm1</italic><sup>-/-</sup> mice could represent a similar scenario as when a viral infection proceeds Mtb infection, as could happen in HIV-infected individuals who are exposed to Mtb. Whether there are aspects of <italic>Irgm1</italic><sup>-/-</sup> mice that model type I IFN induction due to HIV, or other viral, infections is an area for future investigations.</p><p id="P20">The studies herein used germline deletion of <italic>Irgm1</italic> and it still remains unknown what cell types require <italic>Irgm1</italic> expression for control of Mtb infection. <italic>Irgm1</italic>-deficient T cells were able to rescue the susceptibility of <italic>RAG2<sup>-/-</sup></italic> mice to <italic>M. avium</italic> infection, suggesting that the defect in survival following activation was not T cell intrinsic<sup><xref ref-type="bibr" rid="R18">18</xref></sup>. However, <italic>in vitro</italic> studies revealed that IRGM1-deficient T cells exhibit decreased survival and defective expansion following activation in the presence of IFN-g, suggesting that there are T cell intrinsic roles for IRGM1 as well as roles for IRGM1 in other cells that contribute to T cell survival following activation in the presence of IFN-γ<sup><xref ref-type="bibr" rid="R19">19</xref></sup>. Cell type specific effects of IRGM1 expression on type I IFN signaling have also been described, where deletion of <italic>Irgm1</italic> in fibroblasts leads to increased type I IFN due to a defect in mitophagy that is associated with mitochondrial DNA-induced type I IFN responses via the cGAS-STING pathway<sup><xref ref-type="bibr" rid="R62">62</xref></sup>. In contrast, deletion of <italic>Irgm1</italic> in macrophages leads to increased type I IFN signaling via lysosomal toll-like receptors<sup><xref ref-type="bibr" rid="R62">62</xref></sup>. In addition, human IRGM promotes autophagy-mediated degradation of nucleic acid sensors to restrain type I IFN responses in macrophages and epithelial cells<sup><xref ref-type="bibr" rid="R63">63</xref></sup>. Therefore, it is likely that IRGM1 has cell-type specific effects that could differentially impact control of Mtb infection.</p><p id="P21">In humans, a polymorphism in the <italic>IRGM</italic> gene that decreases its expression has been associated with active TB disease in humans<sup><xref ref-type="bibr" rid="R3">3</xref>,<xref ref-type="bibr" rid="R4">4</xref></sup> and given the enhanced susceptibility <italic>Irgm1</italic><sup>-/-</sup> mice to Mtb infection, it is possible there are parallels between the roles for IRGM1 in mice with IRGM in humans. However, interpretating the relationship between human and mouse IRGM homologs is complicated by the expansion of the IRGM family in mice. In mice, IRGM3 often plays a key role in the effects of <italic>Irgm1</italic> deletion. In addition to its role in autophagy<sup><xref ref-type="bibr" rid="R10">10</xref>,<xref ref-type="bibr" rid="R11">11</xref></sup>, IRGM3 regulates endoplasmic reticulum (ER) stress responses in a PI3K/AKT-dependent manner during Coxsackievirus B3 infection<sup><xref ref-type="bibr" rid="R70">70</xref></sup>, where ER stress responses are associated with the induction of type I IFN signaling<sup><xref ref-type="bibr" rid="R71">71</xref>,<xref ref-type="bibr" rid="R72">72</xref></sup>. The contribution of ER stress responses and other yet to be identified roles for IRGM3 in host responses to Mtb infection remains an open question. Understanding the network of IRGM homologs will shed light on cell stress responses and type I IFN signaling during infection.</p></sec><sec id="S9" sec-type="materials | methods"><title>Materials And Methods</title><sec id="S10"><title>Mice</title><p id="P22">WT, <italic>Irgm1<sup>-/-</sup>, Ifnar1<sup>-/-</sup>, Irgm1<sup>-/-</sup>Ifnar1<sup>-/-</sup>, Irgm3<sup>-/-</sup>, Irgm1<sup>-/-</sup>Irgm3<sup>-/-</sup></italic> mice were housed and bred at Washington University in St. Louis specific pathogen-free conditions in accordance with federal and university guidelines, and protocols were approved by the Animal Studies Committee of Washington University. <italic>Irgm1</italic><sup>-/-</sup> and <italic>Ifnar1<sup>-/-</sup></italic> mice were a gift from Dr. Ashley Steed<sup><xref ref-type="bibr" rid="R54">54</xref>,<xref ref-type="bibr" rid="R73">73</xref></sup> at Washington University in St. Louis. <italic>Irgm3<sup>-/-</sup></italic> mice were purchased from Jackson Laboratory <italic>(B6.129-Igtp<sup>tm1Gvw</sup>/J;</italic> 034702). C7 TCR tg/thy1.1 mice were a gift from Dr. Michael Glickman at Sloan Kettering Institute<sup><xref ref-type="bibr" rid="R40">40</xref></sup>. All the mice used for experimental procedures were backcrossed to C57BL/6. Male and female littermates (aged 8–12 weeks) were used and were subject to randomization. All procedures involving animals were conducted following the National Institutes of Health (NIH) guidelines for housing and care of laboratory animals and performed in accordance with institutional regulations after protocol review and approval by the Institutional Animal Care and Use Committee of the Washington University in St. Louis School of Medicine. Washington University is registered as a research facility with the United States Department of Agriculture and is fully accredited by the American Association of Accreditation of Laboratory Animal Care. The Animal Welfare Assurance is on file with Office for Protection from Research Risks–NIH. All animals used in these experiments were subjected to no or minimal discomfort.</p><p id="P23">All mice were euthanized by CO<sub>2</sub> asphyxiation, which is approved by the American Veterinary Association Panel on Euthanasia.</p></sec><sec id="S11"><title>Mtb infection in mice and determination of lung burden</title><p id="P24">Mtb Erdman or GFP-Mtb<sup><xref ref-type="bibr" rid="R31">31</xref>,<xref ref-type="bibr" rid="R32">32</xref></sup> Erdman was cultured at 37° C in 7H9 (broth) or 7H11 (agar) (Difco) medium supplemented with 10% oleic acid/albumin/dextrose/catalase (OADC), 0.5% glycerol, and 0.05% Tween 80 (broth). GFP-Mtb was grown in the presence of kanamycin to ensure plasmid retention. Mtb cultures in logarithmic growth phase (OD600 = 0.5-0.8) were washed with PBS + 0.05% Tween-80, sonicated to disperse clumps, and diluted in sterile water. Mice were infected with 100-200 CFUs of aerosolized Mtb per mouse using an Inhalation Exposure System (Glas-Col). Within 2h of each infection, lungs were harvested from at least two control mice, homogenized, and plated on 7H11 agar to determine the input CFU dose. At each time point after infection, Mtb titers were determined by homogenizing the right lung’s superior, middle, and inferior lobes and plating serial dilutions on 7H11 agar. After 3 weeks of incubation at 37°C in 5% CO2, colonies were counted.</p></sec><sec id="S12"><title>Flow cytometry</title><p id="P25">Lungs were perfused with sterile PBS and the left lobes of the lungs were digested at 37°C with 630 μg/ml collagenase D (Roche) and 75 U/ml DNase I (Sigma). Single-cell suspensions were stained for live-dead Zombie NIR dye (BioLegend) (1:2000) followed by preincubation with Fc Block antibody (BD PharMingen) in PBS + 2% heat-inactivated FBS for 10 min at room temperature before staining. Cells were incubated with the following antibodies: Tcr-β-BV421 (BioLegend #109229;clone H57-597), CD19-pacific blue (BioLegend#115523;clone 6D5), CD44-BV510 (BioLegend#103044;clone IM7), CD4-BV570 (BioLegend#100541;clone RM4-5), Ly-6C-BV605 (BioLegend#128036;clone HK1.4), CD11b-BV650 (BioLegend#101259;clone M1/70), Ly-6G-BV785 (BioLegend#127645;clone 1A8), MHCII-Sparkblue (BioLegend#107662; clone M5/114.15.2), CD11c-PerCP (BioLegend#117325;clone N418), CD64-PerCPefluor710 (Invitrogen#46-0641-82;clone X54-5/7.1), SiglecF-PE (BD#552126;clone E50-2440), CD62L-PE-Cy5 (BioLegend#104410;clone MEL-14), MERTK-PE-Cy7 (Invitrogen#25-5751-82;clone DS5MMER), CD45-AF700 (BioLegend#103128;clone 30-F11), CD8a-APCfire750 (BioLegend#100766;clone 53-6.7). Cells were stained for 20 min at 4°C, washed, and fixed in 4% paraformaldehyde in PBS for 20 min at room temperature. After incubation, cells were washed again with FACS buffer and analyzed on a Cytek Aurora Spectral Flow Cytometer with 4L16V-14B-10YG-*r configuration using SpectroFlo V2.2.0.3 (Cytek). Absolute cell counts were determined by volumetric-based counting on the Cytek Aurora. Flow cytometry data were analyzed using FCS Express 7.12.0005. Gating strategies are depicted in <xref ref-type="supplementary-material" rid="SD2">Fig. S5</xref>.</p></sec><sec id="S13"><title>Cytokine analysis</title><p id="P26">For cytokine analysis, Lungs were homogenized in 5 ml of PBS supplemented with 0.05% Tween 80. Homogenates were filtered (0.22 μm) twice and analyzed by BioPlex-Pro Mouse Cytokine 23-Plex Immunoassay (Bio-Rad). Lung homogenates were quantified for IL-1α, IL-β, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, IL-10, IL-12p40, IL-13, IL-17A, Eotaxin, G-CSF, GM-CSF, IFN-γ, KC, MCP-1, MIP-1α, MIP-1β, RANTES, TNF-α. Cytokines not shown in <xref ref-type="fig" rid="F1">Figure 1</xref> were not significantly different between WT and <italic>Irgm<sup>-/-</sup></italic> mice or were out of the detection range.</p></sec><sec id="S14"><title>Activated T cell transfer and neutrophil depletion</title><p id="P27">ESAT6-specific C7 T cells were isolated from lymph nodes and spleen from C7 TCR tg/thy1.1 transgenic mice with Miltenyi Biotec CD4<sup>+</sup> T cell isolation kit (130-104-454) and the cell purity (95-97%) was assessed by flow cytometry. C7 T cells were activated <italic>in vitro</italic> with ESAT-6 (5μg/ml), anti-IL4 (BioXcell #BE0045 clone 11B11;5μg/ml), and rIL12 (20ng/ml) for two days followed by co-culturing with 50U/ml IL-2 for an additional two days. After four days, T cell activation was assessed by flow cytometry for the expression of T-bet. 2.5 million activated T cells in PBS or the same volume of PBS were transferred intravenously to each mouse one day prior to aerosol infection with Mtb. For neutrophil depletion, mice were intraperitoneally injected every 48 h with 200 μg monoclonal anti-Ly6G antibody (clone 1A8; Leinco) or 200 μg polyclonal rat serum IgG (Sigma-Aldrich) diluted in sterile PBS beginning at 10 dpi and ending at 34 dpi.</p></sec><sec id="S15"><title>RNA isolation, RNAseq, and qRT-PCR analysis</title><p id="P28">RNA was extracted by lysing bulk lung tissue in TRIzol reagent (Invitrogen) using zirconia/silica beads with a FastPrep-24 bead beater (MP Biomedicals) followed by extraction using chloroform. RNA was isolated as per the manufacturer’s instruction using Direct-zol RNA Miniprep Plus kit (Zymo Research).</p><p id="P29">For RNAseq, RNA samples were prepared according to library kit manufacturer’s protocol, indexed, pooled, and sequenced on an Illumina NovaSeq 6000. Basecalls and demultiplexing were performed with Illumina’s bcl2fastq software and a custom python demultiplexing program with a maximum of one mismatch in the indexing read. RNA-seq reads were then aligned to the Ensembl release 76 primary assembly with STAR version 2.5.1a<sup><xref ref-type="bibr" rid="R74">74</xref></sup>. Gene counts were derived from the number of uniquely aligned unambiguous reads by Subread:featureCount version 1.4.6-p5<sup><xref ref-type="bibr" rid="R75">75</xref></sup>. Isoform expression of known Ensembl transcripts were estimated with Salmon version 0.8.2. Sequencing performance was assessed for the total number of aligned reads, total number of uniquely aligned reads, and features detected. The ribosomal fraction, known junction saturation, and read distribution over known gene models were quantified with RSeQC version 2.6.2<sup><xref ref-type="bibr" rid="R76">76</xref></sup>. All gene counts were then imported into the R/Bioconductor package EdgeR<sup><xref ref-type="bibr" rid="R77">77</xref></sup> and TMM normalization size factors were calculated to adjust for samples for differences in library size. The TMM size factors and the matrix of counts were then imported into the R/Bioconductor package Limma<sup><xref ref-type="bibr" rid="R78">78</xref></sup>. Weighted likelihoods based on the observed mean-variance relationship of every gene and sample were then calculated for all samples with Limma’s voomWithQualityWeights<sup><xref ref-type="bibr" rid="R79">79</xref></sup>. The performance of all genes was assessed with plots of the residual standard deviation of every gene to their average log-count with a robustly fitted trend line of the residuals. Differential expression analysis was then performed to analyze for differences between conditions and the results were filtered for only those genes with Benjamini-Hochberg false-discovery rate adjusted p-values less than or equal to 0.05. For each contrast extracted with Limma, gene set enrichment of term in the GO Biological Processes 2021 database were detected using web-based EnrichR<sup><xref ref-type="bibr" rid="R52">52</xref></sup> by checking the number of significantly differentially expressed genes in each contrast to the known terms and calculating enrichment score and P-value. The volcano plot was generated on the Limma extracted contrasts by plotting the -log<sub>10</sub>(P-value) against the log<sub>2</sub>FC. The R/Bioconductor package heatmap3<sup><xref ref-type="bibr" rid="R80">80</xref></sup> was used to display heatmaps for the top 20 differentially expressed genes in each contrast with a Benjamini-Hochberg false-discovery rate adjusted p-value less than or equal to 0.05.</p><p id="P30">For qRT-PCR, cDNA was synthesized using the SuperScript III First-Strand kit (Invitrogen) using oligo(dT) and used for quantitative PCR in a Real-Time PCR System (Bio-Rad CFX96). Target gene cDNAs was detected using the iTaq Universal SYBR Green master mix (Bio-Rad) and the following primer pairs:</p><p id="P31"><italic>Gapdh</italic> forward CTTTGTCAAGCTCATTTCCTGG and reverse TCTTGCTCAGTGTCCTTGC<sup><xref ref-type="bibr" rid="R81">81</xref></sup>, <italic>Oas1</italic> forward CGCACTGGTACCAACTGTGT and reverse CTCCCATACTCCCAGGCATA<sup><xref ref-type="bibr" rid="R54">54</xref></sup>, <italic>Oas2</italic> forward TTGAAGAGGAATACATGCGGAAG and reverse GGGTCTGCATTACTGGCACTT<sup><xref ref-type="bibr" rid="R54">54</xref></sup>, <italic>Mx2</italic> forward GAGGCTCTTCAGAATGAGCAAA and reverse CTCTGCGGTCAGTCTCTCT<sup><xref ref-type="bibr" rid="R54">54</xref></sup>, <italic>Mlkl</italic> forward GGATTGCCCTGAGTTGTTGC and reverse AACCGCAGACAGTCTCTCCA<sup><xref ref-type="bibr" rid="R82">82</xref></sup>, <italic>Ifnb1</italic> forward CGAGCAGAGATCTTCAGGAAC and reverse TCACTACCAGTCCCAGAGTC<sup><xref ref-type="bibr" rid="R81">81</xref></sup>, and <italic>Isg15</italic> forward GCAGACTCCTTAATTCCAGGG and reverse TTCAGTTCTGACACCGTCATG<sup><xref ref-type="bibr" rid="R83">83</xref></sup>. The 2<sup>-ddCt</sup> method was used to analyze the gene expression fold change after normalization with <italic>Gapdh.</italic></p></sec><sec id="S16"><title>Statistical analysis</title><p id="P32">All data are from at least two independent infection experiments with multiple mice in each group. No blinding was performed during animal experiments. Statistical differences were calculated using Prism 9 (GraphPad) using Mantel-Cox tests and Gehan-Breslow-Wilcoxon test (survival), unpaired two-tailed Mann-Whitney tests (to compare two groups with nonparametric data distribution), and one-way ANOVA with Tukey’s multiple comparisons tests (to compare more than two groups with parametric data distribution). Differences with a p-value of &lt;0.05 were defined as statistically significant. Statistical outcomes for each comparison for all graphs are available in <xref ref-type="supplementary-material" rid="SD5">Table S4</xref>.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>List of genes significantly upregulated in the lungs of uninfected Irgm1-/- mice compared to WT</label><media xlink:href="EMS189197-supplement-List_of_genes_significantly_upregulated_in_the_lungs_of_uninfected_Irgm1____mice_compared_to_WT.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d98aAdEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Statistical analysis of samples in the graphs from all figures.</label><media xlink:href="EMS189197-supplement-Statistical_analysis_of_samples_in_the_graphs_from_all_figures_.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d98aAdEcB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><label>Table S1: List of genes significantly downregulated at 21dpi in the lungs of Irgm1-/- mice compared</label><media xlink:href="EMS189197-supplement-Table_S1__List_of_genes_significantly_downregulated_at_21dpi_in_the_lungs_of_Irgm1____mice_compared.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d98aAdEdB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><label>Table S2: List of genes significantly upregulated at 21dpi in the lungs of Irgm1-/- mice compared</label><media xlink:href="EMS189197-supplement-Table_S2__List_of_genes_significantly_upregulated_at_21dpi_in_the_lungs_of_Irgm1____mice_compared.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d98aAdEeB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><label>Supplemental Material</label><media xlink:href="EMS189197-supplement-Supplemental_Material.pdf" mimetype="application" mime-subtype="pdf" id="d98aAdEfB" position="anchor"/></supplementary-material></sec></body><back><ack id="S18"><title>Acknowledgements</title><p>This work was supported by NIH grants R01 AI132697 and U19 AI142784, a Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Disease Award, and the Philip and Sima Needleman Center for Autophagy Therapeutics and Research to C.L.S., a Stephen I. Morse Fellowship to S.K.N., NIH grant T32 AI007172 to M.E.M., a Potts Memorial Foundation postdoctoral fellowship to R.L.K., and a Alexander &amp; Gertrude Berg Fellowship to N.D. We also acknowledge the Genome Technology Access Center at the McDonnell Genome Institute at Washington University School of Medicine for RNA sequencing and analysis. The Center is partially supported by NCI Cancer Center Support Grant #P30 CA91842 to the Siteman Cancer Center and by ICTS/CTSA Grant# UL1TR002345 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. Schematic diagrams were made with BioRender.com. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH. We would also like to thank all Stallings lab members for their fruitful suggestions and discussion.</p></ack><sec id="S17" sec-type="data-availability"><title>Data availability</title><p id="P33">RNA-seq data have been deposited in the NCBI Gene Expression Omnibus (GEO) database and are accessible through the GEO SuperSeries accession number GSExxx. All other relevant data are available from the corresponding author upon reasonable request.</p></sec><fn-group><fn id="FN1" fn-type="con"><p id="P34"><bold>Author contributions</bold></p><p id="P35">S.K.N. and C.L.S. conceived the study and designed the experiments. S.K.N., M.E.M., R.L.K., A.S., C.S.C., S.M., N.D. and R.W. performed the experiments. Y.M. analyzed the RNAseq data. D.K. took care of the mouse breeding and mouse-house facility. S.K.N and C.L.S. wrote the manuscript. M.E.M., Y.M., R.L.K., A.S., C.S.C., S.M., N.D. and R.W. edited the manuscript. C.L.S. directed the study, provided funding, and finalized the manuscript.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="web"><collab>Global tuberculosis report</collab><year>2021</year><comment><ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications-detail-redirect/9789240037021">https://www.who.int/publications-detail-redirect/9789240037021</ext-link></comment></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meunier</surname><given-names>E</given-names></name><name><surname>Broz</surname><given-names>P</given-names></name></person-group><article-title>Interferon-inducible GTPases in cell autonomous and innate immunity</article-title><source>Cellular Microbiology</source><year>2016</year><volume>18</volume><fpage>168</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">26572694</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarroll</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn’s disease</article-title><source>Nat Genet</source><year>2008</year><volume>40</volume><fpage>1107</fpage><lpage>1112</lpage><pub-id pub-id-type="pmcid">PMC2731799</pub-id><pub-id pub-id-type="pmid">19165925</pub-id><pub-id pub-id-type="doi">10.1038/ng.215</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>KY</given-names></name><etal/></person-group><article-title>Polymorphic Allele of Human IRGM1 Is Associated with Susceptibility to Tuberculosis in African Americans</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><elocation-id>e16317</elocation-id><pub-id pub-id-type="pmcid">PMC3025014</pub-id><pub-id pub-id-type="pmid">21283700</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0016317</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilburn</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Differential Requirement for IRGM Proteins during Tuberculosis Infection in Mice</article-title><source>Infect Immun</source><year>2023</year><volume>91</volume><elocation-id>e0051022</elocation-id><pub-id pub-id-type="pmcid">PMC9933630</pub-id><pub-id pub-id-type="pmid">36629440</pub-id><pub-id pub-id-type="doi">10.1128/iai.00510-22</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMicking</surname><given-names>JD</given-names></name><name><surname>Taylor</surname><given-names>GA</given-names></name><name><surname>McKinney</surname><given-names>JD</given-names></name></person-group><article-title>Immune control of tuberculosis by IFN-gamma-inducible LRG-47</article-title><source>Science</source><year>2003</year><volume>302</volume><fpage>654</fpage><lpage>659</lpage><pub-id pub-id-type="pmid">14576437</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Human IRGM regulates autophagy and cell-autonomous immunity functions through mitochondria</article-title><source>Nat Cell Biol</source><year>2010</year><volume>12</volume><fpage>1154</fpage><lpage>1165</lpage><pub-id pub-id-type="pmcid">PMC2996476</pub-id><pub-id pub-id-type="pmid">21102437</pub-id><pub-id pub-id-type="doi">10.1038/ncb2119</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehto</surname><given-names>S</given-names></name><etal/></person-group><article-title>The Crohn’s Disease Risk Factor IRGM Limits NLRP3 Inflammasome Activation by Impeding Its Assembly and by Mediating Its Selective Autophagy</article-title><source>Molecular Cell</source><year>2019</year><volume>73</volume><fpage>429</fpage><lpage>445</lpage><elocation-id>e7</elocation-id><pub-id pub-id-type="pmcid">PMC6372082</pub-id><pub-id pub-id-type="pmid">30612879</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2018.11.018</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Mandell</surname><given-names>MA</given-names></name><name><surname>Deretic</surname><given-names>V</given-names></name></person-group><article-title>IRGM governs the core autophagy machinery to conduct antimicrobial defense</article-title><source>Mol Cell</source><year>2015</year><volume>58</volume><fpage>507</fpage><lpage>521</lpage><pub-id pub-id-type="pmcid">PMC4427528</pub-id><pub-id pub-id-type="pmid">25891078</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2015.03.020</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haldar</surname><given-names>AK</given-names></name><etal/></person-group><article-title>IRG and GBP Host Resistance Factors Target Aberrant, “Non-self” Vacuoles Characterized by the Missing of “Self” IRGM Proteins</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><elocation-id>e1003414</elocation-id><pub-id pub-id-type="pmcid">PMC3681737</pub-id><pub-id pub-id-type="pmid">23785284</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003414</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maric-Biresev</surname><given-names>J</given-names></name><etal/></person-group><article-title>Loss of the interferon-γ-inducible regulatory immunity-related GTPase (IRG), Irgm1, causes activation of effector IRG proteins on lysosomes, damaging lysosomal function and predicting the dramatic susceptibility of Irgm1-deficient mice to infection</article-title><source>BMC Biology</source><year>2016</year><volume>14</volume><fpage>33</fpage><pub-id pub-id-type="pmcid">PMC4837601</pub-id><pub-id pub-id-type="pmid">27098192</pub-id><pub-id pub-id-type="doi">10.1186/s12915-016-0255-4</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>SB</given-names></name><name><surname>Davis</surname><given-names>AS</given-names></name><name><surname>Taylor</surname><given-names>GA</given-names></name><name><surname>Deretic</surname><given-names>V</given-names></name></person-group><article-title>Human IRGM induces autophagy to eliminate intracellular mycobacteria</article-title><source>Science</source><year>2006</year><volume>313</volume><fpage>1438</fpage><lpage>1441</lpage><pub-id pub-id-type="pmid">16888103</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Mandell</surname><given-names>MA</given-names></name><name><surname>Deretic</surname><given-names>V</given-names></name></person-group><article-title>Mechanism of action of the tuberculosis and Crohn disease risk factor IRGM in autophagy</article-title><source>Autophagy</source><year>2016</year><volume>12</volume><fpage>429</fpage><lpage>431</lpage><pub-id pub-id-type="pmcid">PMC4835981</pub-id><pub-id pub-id-type="pmid">26313894</pub-id><pub-id pub-id-type="doi">10.1080/15548627.2015.1084457</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiwari</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>H-P</given-names></name><name><surname>Matsuzawa</surname><given-names>T</given-names></name><name><surname>Pypaert</surname><given-names>M</given-names></name><name><surname>MacMicking</surname><given-names>JD</given-names></name></person-group><article-title>Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria</article-title><source>Nat Immunol</source><year>2009</year><volume>10</volume><fpage>907</fpage><lpage>917</lpage><pub-id pub-id-type="pmcid">PMC2715447</pub-id><pub-id pub-id-type="pmid">19620982</pub-id><pub-id pub-id-type="doi">10.1038/ni.1759</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname><given-names>HM</given-names></name><name><surname>Schramm</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>GA</given-names></name><name><surname>Howard</surname><given-names>JC</given-names></name></person-group><article-title>Irgm1 (LRG-47), a regulator of cell-autonomous immunity, does not localize to mycobacterial or listerial phagosomes in IFN-γ-induced mouse cells</article-title><source>J Immunol</source><year>2013</year><volume>191</volume><fpage>1765</fpage><lpage>1774</lpage><pub-id pub-id-type="pmcid">PMC3753587</pub-id><pub-id pub-id-type="pmid">23842753</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.1300641</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmey</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection</article-title><source>Nature</source><year>2015</year><volume>528</volume><fpage>565</fpage><lpage>569</lpage><pub-id pub-id-type="pmcid">PMC4842313</pub-id><pub-id pub-id-type="pmid">26649827</pub-id><pub-id pub-id-type="doi">10.1038/nature16451</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinsella</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Autophagy prevents early proinflammatory responses and neutrophil recruitment during Mycobacterium tuberculosis infection without affecting pathogen burden in macrophages</article-title><source>PLOS Biology</source><year>2023</year><volume>21</volume><elocation-id>e3002159</elocation-id><pub-id pub-id-type="pmcid">PMC10306192</pub-id><pub-id pub-id-type="pmid">37319285</pub-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3002159</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>CG</given-names></name><etal/></person-group><article-title>Mice Deficient in LRG-47 Display Increased Susceptibility to Mycobacterial Infection Associated with the Induction of Lymphopenia</article-title><source>The Journal of Immunology</source><year>2004</year><volume>172</volume><fpage>1163</fpage><lpage>1168</lpage><pub-id pub-id-type="pmid">14707092</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>CG</given-names></name><etal/></person-group><article-title>The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-γ-induced cell death</article-title><source>Nat Immunol</source><year>2008</year><volume>9</volume><fpage>1279</fpage><lpage>1287</lpage><pub-id pub-id-type="pmcid">PMC2580721</pub-id><pub-id pub-id-type="pmid">18806793</pub-id><pub-id pub-id-type="doi">10.1038/ni.1653</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ky</surname><given-names>K</given-names></name><etal/></person-group><article-title>Irgm1 protects hematopoietic stem cells by negative regulation of IFN signaling</article-title><source>Blood</source><year>2011</year><volume>118</volume><pub-id pub-id-type="pmcid">PMC3156044</pub-id><pub-id pub-id-type="pmid">21633090</pub-id><pub-id pub-id-type="doi">10.1182/blood-2011-01-328682</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Weksberg</surname><given-names>DC</given-names></name><name><surname>Taylor</surname><given-names>GA</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><name><surname>Goodell</surname><given-names>MA</given-names></name></person-group><article-title>The p47 GTPase Lrg-47 (Irgm1) Links Host Defense and Hematopoietic Stem Cell Proliferation</article-title><source>Cell Stem Cell</source><year>2008</year><volume>2</volume><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="pmcid">PMC2278017</pub-id><pub-id pub-id-type="pmid">18371424</pub-id><pub-id pub-id-type="doi">10.1016/j.stem.2007.10.007</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Irgm1-deficiency leads to myeloid dysfunction in colon lamina propria and susceptibility to the intestinal pathogen Citrobacter rodentium</article-title><source>PLOS Pathogens</source><year>2020</year><volume>16</volume><elocation-id>e1008553</elocation-id><pub-id pub-id-type="pmcid">PMC7274479</pub-id><pub-id pub-id-type="pmid">32453761</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008553</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Balance of Irgm protein activities determines IFN-γ-induced host defense</article-title><source>Journal of Leukocyte Biology</source><year>2009</year><volume>85</volume><fpage>877</fpage><lpage>885</lpage><pub-id pub-id-type="pmcid">PMC2669409</pub-id><pub-id pub-id-type="pmid">19176402</pub-id><pub-id pub-id-type="doi">10.1189/jlb.1008599</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>SB</given-names></name><etal/></person-group><article-title>Alveolar Macrophages Provide an Early Mycobacterium tuberculosis Niche and Initiate Dissemination</article-title><source>Cell Host Microbe</source><year>2018</year><volume>24</volume><fpage>439</fpage><lpage>446</lpage><elocation-id>e4</elocation-id><pub-id pub-id-type="pmcid">PMC6152889</pub-id><pub-id pub-id-type="pmid">30146391</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2018.08.001</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothchild</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo</article-title><source>Sci Immunol</source><year>2019</year><volume>4</volume><elocation-id>eaaw6693</elocation-id><pub-id pub-id-type="pmcid">PMC6910245</pub-id><pub-id pub-id-type="pmid">31350281</pub-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aaw6693</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlap</surname><given-names>MD</given-names></name><etal/></person-group><article-title>A novel role for C-C motif chemokine receptor 2 during infection with hypervirulent Mycobacterium tuberculosis</article-title><source>Mucosal Immunol</source><year>2018</year><volume>11</volume><fpage>1727</fpage><lpage>1742</lpage><pub-id pub-id-type="pmcid">PMC6279476</pub-id><pub-id pub-id-type="pmid">30115997</pub-id><pub-id pub-id-type="doi">10.1038/s41385-018-0071-y</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs</article-title><source>Journal of Experimental Medicine</source><year>2007</year><volume>205</volume><fpage>105</fpage><lpage>115</lpage><pub-id pub-id-type="pmcid">PMC2234384</pub-id><pub-id pub-id-type="pmid">18158321</pub-id><pub-id pub-id-type="doi">10.1084/jem.20071367</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>S</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group><article-title>Cell-to-cell transfer of M. tuberculosis antigens optimizes CD4 T cell priming</article-title><source>Cell Host Microbe</source><year>2014</year><volume>15</volume><fpage>741</fpage><lpage>752</lpage><pub-id pub-id-type="pmcid">PMC4098643</pub-id><pub-id pub-id-type="pmid">24922576</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2014.05.007</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chackerian</surname><given-names>AA</given-names></name><name><surname>Alt</surname><given-names>JM</given-names></name><name><surname>Perera</surname><given-names>TV</given-names></name><name><surname>Dascher</surname><given-names>CC</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group><article-title>Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><fpage>4501</fpage><lpage>4509</lpage><pub-id pub-id-type="pmcid">PMC128141</pub-id><pub-id pub-id-type="pmid">12117962</pub-id><pub-id pub-id-type="doi">10.1128/IAI.70.8.4501-4509.2002</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakai</surname><given-names>S</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name></person-group><article-title>Defining features of protective CD4 T cell responses to Mycobacterium tuberculosis</article-title><source>Curr Opin Immunol</source><year>2014</year><volume>29</volume><fpage>137</fpage><lpage>142</lpage><pub-id pub-id-type="pmcid">PMC4122329</pub-id><pub-id pub-id-type="pmid">25000593</pub-id><pub-id pub-id-type="doi">10.1016/j.coi.2014.06.003</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huynh</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection</article-title><source>J Exp Med</source><year>2018</year><volume>215</volume><fpage>1823</fpage><lpage>1838</lpage><pub-id pub-id-type="pmcid">PMC6028511</pub-id><pub-id pub-id-type="pmid">29773644</pub-id><pub-id pub-id-type="doi">10.1084/jem.20171704</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>S</given-names></name><etal/></person-group><article-title>Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection</article-title><source>Journal of Experimental Medicine</source><year>2018</year><volume>215</volume><fpage>1035</fpage><lpage>1045</lpage><pub-id pub-id-type="pmcid">PMC5881474</pub-id><pub-id pub-id-type="pmid">29511063</pub-id><pub-id pub-id-type="doi">10.1084/jem.20180118</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samstein</surname><given-names>M</given-names></name><etal/></person-group><article-title>Essential yet limited role for CCR2+ inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming</article-title><source>eLife</source><year>2013</year><volume>2</volume><elocation-id>e01086</elocation-id><pub-id pub-id-type="pmcid">PMC3820971</pub-id><pub-id pub-id-type="pmid">24220507</pub-id><pub-id pub-id-type="doi">10.7554/eLife.01086</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmey</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection</article-title><source>Nature</source><year>2015</year><volume>528</volume><fpage>565</fpage><lpage>569</lpage></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jc</surname><given-names>L</given-names></name><etal/></person-group><article-title>Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice</article-title><source>Journal of immunology (Baltimore, Md. : 1950)</source><year>2001</year><volume>166</volume><pub-id pub-id-type="pmid">11254718</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fielding</surname><given-names>CA</given-names></name><etal/></person-group><article-title>IL-6 Regulates Neutrophil Trafficking during Acute Inflammation via STAT3</article-title><source>The Journal of Immunology</source><year>2008</year><volume>181</volume><fpage>2189</fpage><lpage>2195</lpage><pub-id pub-id-type="pmid">18641358</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritzman</surname><given-names>AM</given-names></name><etal/></person-group><article-title>The Chemokine Receptor CXCR2 Ligand KC (CXCL1) Mediates Neutrophil Recruitment and Is Critical for Development of Experimental Lyme Arthritis and Carditis</article-title><source>Infect Immun</source><year>2010</year><volume>78</volume><fpage>4593</fpage><lpage>4600</lpage><pub-id pub-id-type="pmcid">PMC2976349</pub-id><pub-id pub-id-type="pmid">20823213</pub-id><pub-id pub-id-type="doi">10.1128/IAI.00798-10</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balamayooran</surname><given-names>G</given-names></name><name><surname>Batra</surname><given-names>S</given-names></name><name><surname>Balamayooran</surname><given-names>T</given-names></name><name><surname>Cai</surname><given-names>S</given-names></name><name><surname>Jeyaseelan</surname><given-names>S</given-names></name></person-group><article-title>Monocyte Chemoattractant Protein 1 Regulates Pulmonary Host Defense via Neutrophil Recruitment during Escherichia coli Infection <sup>v</sup></article-title><source>Infect Immun</source><year>2011</year><volume>79</volume><fpage>2567</fpage><lpage>2577</lpage><pub-id pub-id-type="pmcid">PMC3191985</pub-id><pub-id pub-id-type="pmid">21518788</pub-id><pub-id pub-id-type="doi">10.1128/IAI.00067-11</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Intrapulmonary Expression of Macrophage Inflammatory Protein 1α (CCL3) Induces Neutrophil and NK Cell Accumulation and Stimulates Innate Immunity in Murine Bacterial Pneumonia</article-title><source>Infection and Immunity</source><year>2003</year><volume>71</volume><fpage>1306</fpage><lpage>1315</lpage><pub-id pub-id-type="pmcid">PMC148850</pub-id><pub-id pub-id-type="pmid">12595446</pub-id><pub-id pub-id-type="doi">10.1128/IAI.71.3.1306-1315.2003</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallegos</surname><given-names>AM</given-names></name><name><surname>Pamer</surname><given-names>EG</given-names></name><name><surname>Glickman</surname><given-names>MS</given-names></name></person-group><article-title>Delayed protection by ESAT-6–specific effector CD4+ T cells after airborne M. tuberculosis infection</article-title><source>Journal of Experimental Medicine</source><year>2008</year><volume>205</volume><fpage>2359</fpage><lpage>2368</lpage><pub-id pub-id-type="pmcid">PMC2556792</pub-id><pub-id pub-id-type="pmid">18779346</pub-id><pub-id pub-id-type="doi">10.1084/jem.20080353</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nandi</surname><given-names>B</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group><article-title>Regulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection</article-title><source>Journal of Experimental Medicine</source><year>2011</year><volume>208</volume><fpage>2251</fpage><lpage>2262</lpage><pub-id pub-id-type="pmcid">PMC3201199</pub-id><pub-id pub-id-type="pmid">21967766</pub-id><pub-id pub-id-type="doi">10.1084/jem.20110919</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>BB</given-names></name><etal/></person-group><article-title>Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis</article-title><source>Nat Microbiol</source><year>2017</year><volume>2</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmcid">PMC5461879</pub-id><pub-id pub-id-type="pmid">28504669</pub-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2017.72</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira-Teixeira</surname><given-names>L</given-names></name><etal/></person-group><article-title>Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis</article-title><source>Nat Commun</source><year>2020</year><volume>11</volume><elocation-id>5566</elocation-id><pub-id pub-id-type="pmcid">PMC7643080</pub-id><pub-id pub-id-type="pmid">33149141</pub-id><pub-id pub-id-type="doi">10.1038/s41467-020-19412-6</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>ACC</given-names></name><etal/></person-group><article-title>Pre-Treatment Neutrophil Count as a Predictor of Antituberculosis Therapy Outcomes: A Multicenter Prospective Cohort Study</article-title><source>Frontiers in Immunology</source><year>2021</year><volume>12</volume><pub-id pub-id-type="pmcid">PMC8284392</pub-id><pub-id pub-id-type="pmid">34276654</pub-id><pub-id pub-id-type="doi">10.3389/fimmu.2021.661934</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Y</given-names></name><etal/></person-group><article-title>High blood neutrophil-lymphocyte ratio associated with poor outcomes in miliary tuberculosis</article-title><source>J Thorac Dis</source><year>2018</year><volume>10</volume><fpage>339</fpage><lpage>346</lpage><pub-id pub-id-type="pmcid">PMC5863179</pub-id><pub-id pub-id-type="pmid">29600065</pub-id><pub-id pub-id-type="doi">10.21037/jtd.2017.12.65</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lowe</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Neutrophilia independently predicts death in tuberculosis</article-title><source>Eur Respir J</source><year>2013</year><volume>42</volume><fpage>1752</fpage><lpage>1757</lpage><pub-id pub-id-type="pmcid">PMC4176760</pub-id><pub-id pub-id-type="pmid">24114967</pub-id><pub-id pub-id-type="doi">10.1183/09031936.00140913</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MPR</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="pmcid">PMC3492754</pub-id><pub-id pub-id-type="pmid">20725040</pub-id><pub-id pub-id-type="doi">10.1038/nature09247</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinholz</surname><given-names>CL</given-names></name><etal/></person-group><article-title>Ly6G deficiency alters the dynamics of neutrophil recruitment and pathogen capture during Leishmania major skin infection</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><elocation-id>15071</elocation-id><pub-id pub-id-type="pmcid">PMC8302578</pub-id><pub-id pub-id-type="pmid">34302006</pub-id><pub-id pub-id-type="doi">10.1038/s41598-021-94425-9</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>S</given-names></name><etal/></person-group><article-title>Autophagy protects against high-dose Mycobacterium tuberculosis infection</article-title><year>2022</year><elocation-id>2022.11.04.515158</elocation-id><pub-id pub-id-type="doi">10.1101/2022.11.04.515158</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><etal/></person-group><article-title>CD11cHi monocyte-derived macrophages are a major cellular compartment infected by Mycobacterium tuberculosis</article-title><source>PLOS Pathogens</source><year>2020</year><volume>16</volume><elocation-id>e1008621</elocation-id><pub-id pub-id-type="pmcid">PMC7319360</pub-id><pub-id pub-id-type="pmid">32544188</pub-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1008621</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindsay</surname><given-names>RS</given-names></name><etal/></person-group><article-title>MERTK on mononuclear phagocytes regulates T cell antigen recognition at autoimmune and tumor sites</article-title><source>J Exp Med</source><year>2021</year><volume>218</volume><elocation-id>e20200464</elocation-id><pub-id pub-id-type="pmcid">PMC8383814</pub-id><pub-id pub-id-type="pmid">34415994</pub-id><pub-id pub-id-type="doi">10.1084/jem.20200464</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>EY</given-names></name><etal/></person-group><article-title>Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool</article-title><source>BMC Bioinformatics</source><year>2013</year><volume>14</volume><fpage>128</fpage><pub-id pub-id-type="pmcid">PMC3637064</pub-id><pub-id pub-id-type="pmid">23586463</pub-id><pub-id pub-id-type="doi">10.1186/1471-2105-14-128</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M</given-names></name><etal/></person-group><article-title>Gene Ontology: tool for the unification of biology</article-title><source>Nat Genet</source><year>2000</year><volume>25</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="pmcid">PMC3037419</pub-id><pub-id pub-id-type="pmid">10802651</pub-id><pub-id pub-id-type="doi">10.1038/75556</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steed</surname><given-names>AL</given-names></name><etal/></person-group><article-title>The microbial metabolite desaminotyrosine protects from influenza through type I interferon</article-title><source>Science</source><year>2017</year><volume>357</volume><fpage>498</fpage><lpage>502</lpage><pub-id pub-id-type="pmcid">PMC5753406</pub-id><pub-id pub-id-type="pmid">28774928</pub-id><pub-id pub-id-type="doi">10.1126/science.aam5336</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><etal/></person-group><article-title>Type I Interferons Link Viral Infection to Enhanced Epithelial Turnover and Repair</article-title><source>Cell Host &amp; Microbe</source><year>2015</year><volume>17</volume><fpage>85</fpage><lpage>97</lpage><pub-id pub-id-type="pmcid">PMC4297260</pub-id><pub-id pub-id-type="pmid">25482432</pub-id><pub-id pub-id-type="doi">10.1016/j.chom.2014.11.004</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nath</surname><given-names>P</given-names></name><etal/></person-group><article-title>Inhibition of IRGM establishes a robust antiviral immune state to restrict pathogenic viruses</article-title><source>EMBO reports</source><year>2021</year><volume>22</volume><elocation-id>e52948</elocation-id><pub-id pub-id-type="pmcid">PMC8567234</pub-id><pub-id pub-id-type="pmid">34467632</pub-id><pub-id pub-id-type="doi">10.15252/embr.202152948</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinsella</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Perspectives and Advances in the Understanding of Tuberculosis</article-title><source>Annu Rev Pathol</source><year>2021</year><volume>16</volume><fpage>377</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">33497258</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><etal/></person-group><article-title>Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway</article-title><source>J Interferon Cytokine Res</source><year>2005</year><volume>25</volume><fpage>694</fpage><lpage>701</lpage><pub-id pub-id-type="pmid">16318583</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimmey</surname><given-names>JM</given-names></name><etal/></person-group><article-title>The impact of ISGylation during Mycobacterium tuberculosis infection in mice</article-title><source>Microbes Infect</source><year>2017</year><volume>19</volume><fpage>249</fpage><lpage>258</lpage><pub-id pub-id-type="pmcid">PMC5403610</pub-id><pub-id pub-id-type="pmid">28087453</pub-id><pub-id pub-id-type="doi">10.1016/j.micinf.2016.12.006</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics</article-title><source>Eur J Immunol</source><year>2014</year><volume>44</volume><fpage>2380</fpage><lpage>2393</lpage><pub-id pub-id-type="pmcid">PMC4298793</pub-id><pub-id pub-id-type="pmid">24782112</pub-id><pub-id pub-id-type="doi">10.1002/eji.201344219</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>P</given-names></name><etal/></person-group><article-title>IRGM1 supports host defense against intracellular bacteria through suppression of type I interferon in mice</article-title><source>J Clin Invest</source><year>2023</year><elocation-id>e171982</elocation-id><pub-id pub-id-type="pmcid">PMC10617763</pub-id><pub-id pub-id-type="pmid">37698925</pub-id><pub-id pub-id-type="doi">10.1172/JCI171982</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname><given-names>P</given-names></name><etal/></person-group><article-title>IRGM1 links mitochondrial quality control to autoimmunity</article-title><source>Nat Immunol</source><year>2021</year><volume>22</volume><fpage>312</fpage><lpage>321</lpage><pub-id pub-id-type="pmcid">PMC7906953</pub-id><pub-id pub-id-type="pmid">33510463</pub-id><pub-id pub-id-type="doi">10.1038/s41590-020-00859-0</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jena</surname><given-names>KK</given-names></name><etal/></person-group><article-title>Autoimmunity gene IRGM suppresses cGAS-STING and RIG-I-MAVS signaling to control interferon response</article-title><source>EMBO reports</source><year>2020</year><volume>21</volume><elocation-id>e50051</elocation-id><pub-id pub-id-type="pmcid">PMC7507369</pub-id><pub-id pub-id-type="pmid">32715615</pub-id><pub-id pub-id-type="doi">10.15252/embr.202050051</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Activated STING in a Vascular and Pulmonary Syndrome</article-title><source>New England Journal of Medicine</source><year>2014</year><volume>371</volume><fpage>507</fpage><lpage>518</lpage><pub-id pub-id-type="pmcid">PMC4174543</pub-id><pub-id pub-id-type="pmid">25029335</pub-id><pub-id pub-id-type="doi">10.1056/NEJMoa1312625</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname><given-names>JD</given-names></name><etal/></person-group><article-title>STING-associated vasculopathy develops independently of IRF3 in mice</article-title><source>Journal of Experimental Medicine</source><year>2017</year><volume>214</volume><fpage>3279</fpage><lpage>3292</lpage><pub-id pub-id-type="pmcid">PMC5679177</pub-id><pub-id pub-id-type="pmid">28951494</pub-id><pub-id pub-id-type="doi">10.1084/jem.20171351</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frémond</surname><given-names>M-L</given-names></name><etal/></person-group><article-title>Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients</article-title><source>J Allergy Clin Immunol Pract</source><year>2021</year><volume>9</volume><fpage>803</fpage><lpage>818</lpage><elocation-id>e11</elocation-id><pub-id pub-id-type="pmid">33217613</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luksch</surname><given-names>H</given-names></name><etal/></person-group><article-title>STING-associated lung disease in mice relies on T cells but not type I interferon</article-title><source>J Allergy Clin Immunol</source><year>2019</year><volume>144</volume><fpage>254</fpage><lpage>266</lpage><elocation-id>e8</elocation-id><pub-id pub-id-type="pmcid">PMC6612314</pub-id><pub-id pub-id-type="pmid">30772497</pub-id><pub-id pub-id-type="doi">10.1016/j.jaci.2019.01.044</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennion</surname><given-names>BG</given-names></name><etal/></person-group><article-title>STING Gain-of-Function Disrupts Lymph Node Organogenesis and Innate Lymphoid Cell Development in Mice</article-title><source>Cell Rep</source><year>2020</year><volume>31</volume><elocation-id>107771</elocation-id><pub-id pub-id-type="pmcid">PMC7372600</pub-id><pub-id pub-id-type="pmid">32553167</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107771</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stinson</surname><given-names>WA</given-names></name><etal/></person-group><article-title>The IFN-γ receptor promotes immune dysregulation and disease in STING gain-of-function mice</article-title><source>JCI Insight</source><volume>7</volume><elocation-id>e155250</elocation-id><pub-id pub-id-type="pmcid">PMC9536275</pub-id><pub-id pub-id-type="pmid">36073546</pub-id><pub-id pub-id-type="doi">10.1172/jci.insight.155250</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>The Immunity-related GTPase Irgm3 Relieves Endoplasmic Reticulum Stress Response during Coxsackievirus B3 Infection via a PI3K/Akt Dependent Pathway</article-title><source>Cell Microbiol</source><year>2012</year><volume>14</volume><fpage>133</fpage><lpage>146</lpage><pub-id pub-id-type="pmcid">PMC3691006</pub-id><pub-id pub-id-type="pmid">21981022</pub-id><pub-id pub-id-type="doi">10.1111/j.1462-5822.2011.01708.x</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Barber</surname><given-names>GN</given-names></name></person-group><article-title>STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling</article-title><source>Nature</source><year>2008</year><volume>455</volume><fpage>674</fpage><lpage>678</lpage><pub-id pub-id-type="pmcid">PMC2804933</pub-id><pub-id pub-id-type="pmid">18724357</pub-id><pub-id pub-id-type="doi">10.1038/nature07317</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y-P</given-names></name><etal/></person-group><article-title>Endoplasmic Reticulum Stress Regulates the Innate Immunity Critical Transcription Factor IRF3</article-title><source>The Journal of Immunology</source><year>2012</year><volume>189</volume><fpage>4630</fpage><lpage>4639</lpage><pub-id pub-id-type="pmcid">PMC3478468</pub-id><pub-id pub-id-type="pmid">23028052</pub-id><pub-id pub-id-type="doi">10.4049/jimmunol.1102737</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collazo</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Inactivation of Lrg-47 and Irg-47 Reveals a Family of Interferon γ– Inducible Genes with Essential, Pathogen-Specific Roles in Resistance to Infection</article-title><source>J Exp Med</source><year>2001</year><volume>194</volume><fpage>181</fpage><lpage>188</lpage><pub-id pub-id-type="pmcid">PMC2193451</pub-id><pub-id pub-id-type="pmid">11457893</pub-id><pub-id pub-id-type="doi">10.1084/jem.194.2.181</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><etal/></person-group><article-title>STAR: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><year>2013</year><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="pmcid">PMC3530905</pub-id><pub-id pub-id-type="pmid">23104886</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>Y</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name></person-group><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><year>2014</year><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>W</given-names></name></person-group><article-title>RSeQC: quality control of RNA-seq experiments</article-title><source>Bioinformatics</source><year>2012</year><volume>28</volume><fpage>2184</fpage><lpage>2185</lpage><pub-id pub-id-type="pmid">22743226</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>MD</given-names></name><name><surname>McCarthy</surname><given-names>DJ</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name></person-group><article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>139</fpage><lpage>140</lpage><pub-id pub-id-type="pmcid">PMC2796818</pub-id><pub-id pub-id-type="pmid">19910308</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>ME</given-names></name><etal/></person-group><article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title><source>Nucleic Acids Res</source><year>2015</year><volume>43</volume><fpage>e47</fpage><pub-id pub-id-type="pmcid">PMC4402510</pub-id><pub-id pub-id-type="pmid">25605792</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>R</given-names></name><etal/></person-group><article-title>Why weight? Modelling sample and observational level variability improves power in RNA-seq analyses</article-title><source>Nucleic Acids Res</source><year>2015</year><volume>43</volume><fpage>e97</fpage><pub-id pub-id-type="pmcid">PMC4551905</pub-id><pub-id pub-id-type="pmid">25925576</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkv412</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Sheng</surname><given-names>Q</given-names></name><name><surname>Shyr</surname><given-names>Y</given-names></name></person-group><article-title>Advanced Heat Map and Clustering Analysis Using Heatmap3</article-title><source>BioMed Research International</source><year>2014</year><volume>2014</volume><elocation-id>e986048</elocation-id><pub-id pub-id-type="pmcid">PMC4124803</pub-id><pub-id pub-id-type="pmid">25143956</pub-id><pub-id pub-id-type="doi">10.1155/2014/986048</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants</article-title><source>J Clin Invest</source><year>2015</year><volume>125</volume><fpage>2532</fpage><lpage>2546</lpage><pub-id pub-id-type="pmcid">PMC4497758</pub-id><pub-id pub-id-type="pmid">25938786</pub-id><pub-id pub-id-type="doi">10.1172/JCI79915</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL</article-title><source>J Biol Chem</source><year>2013</year><volume>288</volume><fpage>31268</fpage><lpage>31279</lpage><pub-id pub-id-type="pmcid">PMC3829437</pub-id><pub-id pub-id-type="pmid">24019532</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M113.462341</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purman</surname><given-names>CE</given-names></name><etal/></person-group><article-title>Regional Gene Repression by DNA Double-Strand Breaks in G1 Phase Cells</article-title><source>Mol Cell Biol</source><year>2019</year><volume>39</volume><elocation-id>e00181-19</elocation-id><pub-id pub-id-type="pmcid">PMC6879199</pub-id><pub-id pub-id-type="pmid">31591143</pub-id><pub-id pub-id-type="doi">10.1128/MCB.00181-19</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig. 1</label><caption><title>Susceptibility of <italic>Irgm1</italic><sup>-/-</sup> mice to Mtb infection is associated with impaired T cell expansion in the dLN and defects in innate immune cells in the lung</title><p><bold>(A)</bold> Survival of WT and <italic>Irgm1</italic><sup>-/-</sup> mice following Mtb aerosol infection (WT n=5, <italic>Irgm1</italic><sup>-/-</sup> n=4). Statistical significance of differences was determined by the Mantel-Cox test (**P &lt; 0.01). <bold>(B)</bold> Mtb CFU count in lungs at 21 dpi. <bold>(C)</bold> Representative mediastinal dLN from WT and <italic>Irgm11<sup>-/-</sup></italic> mice at 21 dpi. <bold>(D-F)</bold> Number of <bold>(D)</bold> CD4<sup>+</sup> and CD8<sup>+</sup> T cells, <bold>(E)</bold> activated CD4<sup>+</sup> T cells (CD44<sup>+</sup>CD62L<sup>-</sup>), and <bold>(F)</bold> DCs in the dLN at 21 dpi. <bold>(G)</bold> % of activated CD4<sup>+</sup> T cells that were Zombie<sup>+</sup> (nonviable) in the dLN at 21 dpi. <bold>(H-J)</bold> Number of <bold>(H)</bold> CD4<sup>+</sup> T cells and activated CD4<sup>+</sup> T cells, <bold>(I)</bold> non-alveolar macrophages and DCs, and <bold>(J)</bold> neutrophils and alveolar macrophages (AM) in the lungs at 21 dpi. <bold>(K)</bold> Representative flow plot showing Mtb-GFP positivity in Ly6G<sup>+</sup> neutrophils in the lung at 21 dpi. <bold>(L)</bold> Number of Mtb<sup>+</sup> (based on GFP from Mtb-GFP) neutrophils and Mtb burden (based on mean fluorescence intensity (MFI) of GFP) per infected neutrophil in the lung at 21 dpi. <bold>(M)</bold> Number of Mtb<sup>+</sup> AMs in the lung at 21 dpi. <bold>(N-O)</bold> Cytokine and chemokine levels in bulk lung homogenate at 21 dpi. Each data point corresponds to one mouse and graphs show the mean ± SEM, where in <bold>(D-J, L-O)</bold> the data are expressed as the ratio to the average for WT in a single infection experiment to mitigate inter-experiment variation in total cell counts. <bold>(D-J)</bold> Data is combined from experiments using both WT Mtb Erdman strain and GFP expressing Mtb (GFP-Mtb). <bold>(B, D-J, L-O)</bold> Statistical significance of differences were determined by two-tailed unpaired t-tests. **** P &lt; 0.0001; *** P &lt; 0.001; ** P &lt; 0.01; * P &lt; 0.05; ns=not significant.</p></caption><graphic xlink:href="EMS189197-f001"/></fig><fig id="F2" position="float"><label>Fig. 2</label><caption><title>Adoptive transfer of activated Mtb-specific CD4<sup>+</sup> T cell rescues control of Mtb infection in innate immune cells and allows for survival of <italic>Irgm1</italic><sup>-/-</sup> mice</title><p><bold>(A)</bold> Protocol schematic for activation and adoptive transfer of Mtb ESAT-6-specific C7 transgenic CD4<sup>+</sup> T cells to mice prior to Mtb aerosol infection and analysis of immune cells at 21dpi. <bold>(B)</bold> Before transfer, isolated CD4<sup>+</sup> T cells were analyzed for T-bet expression as a proxy of activation status after being stimulated <italic>in vitro</italic> with ESAT-6 peptide, a-IL-4, IL-12, and IL-2 or being left unstimulated. <bold>(C-H)</bold> Number of <bold>(C)</bold> C7 Thy1.1<sup>+</sup>CD4<sup>+</sup> T cells, <bold>(D)</bold> DCs, <bold>(E)</bold> non-alveolar macrophages, <bold>(F)</bold> neutrophils, <bold>(G)</bold> AMs, and <bold>(H)</bold> Mtb<sup>+</sup> neutrophils and AMs (based on GFP from Mtb-GFP) in the lungs of mice at 21 dpi that either received activated C7 CD4<sup>+</sup> T cells (+) or PBS (-). <bold>(I)</bold> Mtb burden (based on MFI of GFP) per infected neutrophil in the lung at 21 dpi. <bold>(J)</bold> Mtb CFU count in lungs at 21 dpi. <bold>(K)</bold> Survival of mice following Mtb infection, where statistical significance was determined by Mantel-Cox test (**P=0.0017). (n=5 for each strain and condition). <bold>(C-J)</bold> Each data point corresponds to one mouse and graphs show the mean ± SEM, where in <bold>(D-I)</bold> the data are expressed as the ratio to the average for WT administered PBS in a single infection experiment to mitigate inter-experiment variation in total cell counts. Statistical significance of differences within a single mouse strain or treatment condition were determined by <bold>(C)</bold> two-tailed unpaired t-tests or <bold>(D-J)</bold> one-way ANOVA with Tukey’s multiple comparison test. **** P &lt; 0.0001; *** P &lt; 0.001; ** P &lt; 0.01; * P &lt; 0.05; ns=not significant.</p></caption><graphic xlink:href="EMS189197-f002"/></fig><fig id="F3" position="float"><label>Fig. 3</label><caption><title>Neutrophil depletion extends the survival of <italic>Irgm1</italic><sup>-/-</sup> mice during Mtb infection</title><p><bold>(A)</bold> Survival of WT and <italic>Irgm1</italic><sup>-/-</sup> mice following Mtb aerosol infection and administration of an αLy6G antibody to deplete neutrophils or an IgG control antibody (n=4 for each strain and condition). Statistical significance of difference in survival between <italic>Irgm1</italic><sup>-/-</sup> mice treated with αLy6G antibody versus IgG control was determined by Mantel-Cox test (*P&lt;0.05). <bold>(B)</bold> Representative flow plot showing successful depletion of Gr1<sup>hi</sup> neutrophils, but not Gr1<sup>int</sup> cells, upon αLy6G administration in both WT and <italic>Irgm1</italic><sup>-/-</sup> mice. <bold>(C-D)</bold> Number of <bold>(C)</bold> Gr1<sup>hi</sup> neutrophils and <bold>(D)</bold> Mtb<sup>+</sup> Gr1<sup>hi</sup> neutrophils in the lungs at 21dpi following administration of αLy6G antibody (+) or an IgG control antibody (-). <bold>(E-G)</bold> Mtb burden (based on MFI of GFP) per infected cells in <bold>(E)</bold> Mtb<sup>+</sup>Gr1<sup>int</sup>Ly6C<sup>hi</sup> <bold>(F)</bold> Mtb<sup>+</sup>Gr1<sup>int</sup>MERTK-Ly6C<sup>lo</sup> and <bold>(G)</bold> Mtb<sup>+</sup>Gr1<sup>int</sup>MERTK<sup>+</sup>Ly6C<sup>lo</sup> cells at 21dpi in the WT and <italic>Irgm1</italic><sup>-/-</sup> mouse lung following administration of αLy6G antibody (+) or IgG (-). <bold>(H-K)</bold> Number of <bold>(H)</bold> AMs, <bold>(I)</bold> Mtb<sup>+</sup> AMs, <bold>(J)</bold> DCs, and <bold>(K)</bold> non-alveolar macrophages in the lungs at 21dpi. <bold>(L)</bold> Mtb CFU count in the lung at 21dpi per WT IgG average; CFU values were presented as a ratio to mitigate the variation between experiments and the raw values are shown in <xref ref-type="supplementary-material" rid="SD2">Fig. S3I</xref>. <bold>(M)</bold> Number of CD4<sup>+</sup> T cells and activated CD4<sup>+</sup> T cells in the lungs at 21 dpi. Each data point corresponds to one mouse and graphs show the mean ± SEM, where in <bold>(C-M)</bold> the data are expressed as the ratio to the average for WT administered IgG control antibody in a single infection experiment to mitigate inter-experiment variation in total cell counts. <bold>(C-M)</bold> Statistical significance of differences within a single mouse strain or treatment condition were determined by one-way ANOVA’s Tukey’s multiple comparison test. **** P &lt; 0.0001; ** P &lt; 0.01; * P &lt; 0.05. ns=not significant.</p></caption><graphic xlink:href="EMS189197-f003"/></fig><fig id="F4" position="float"><label>Fig. 4</label><caption><title>Increased type I IFN signaling in <italic>Irgm1</italic><sup>-/-</sup> mice causes defects in T cell expansion and susceptibility during Mtb infection</title><p><bold>(A)</bold> Ten most enriched pathways in the upregulated genes from bulk RNAseq analysis of total lung from <italic>Irgm1</italic><sup>-/-</sup> mice compared to WT controls at 21 dpi. <bold>(B)</bold> qRT-PCR analysis of ISG expression in lungs of <italic>Irgm1</italic><sup>-/-</sup> mice compared to WT controls at 21 dpi. Significance of differences were determined by two-tailed unpaired t-test. *** P &lt; 0.001; * P &lt; 0.05. <bold>(C)</bold> Survival of mice following Mtb infection (WT n=5, <italic>Irgm1</italic><sup>-/-</sup> n=4, <italic>Irgm1<sup>-/-</sup>/Ifnar1<sup>-/-</sup></italic> n=9, <italic>Ifnar1<sup>-/-</sup></italic> n=5). Statistical significance of differences in survival compared to <italic>Irgm1</italic><sup>-/-</sup> mice determined by Mantel-Cox test. <bold>(D)</bold> Representative mediastinal dLN from WT and <italic>Irgm1<sup>-/-</sup>/Ifnar1<sup>-/-</sup></italic> mice at 21 dpi. <bold>(E)</bold> Number of CD4<sup>+</sup> T cells, activated CD4<sup>+</sup> T cells (CD44<sup>+</sup>), and DCs in the dLN at 21dpi. The legend in <bold>(E)</bold> applies to all subsequent panels. <bold>(F-L)</bold> Number of <bold>(F)</bold> CD4<sup>+</sup>T cells and activated CD4<sup>+</sup>(CD44<sup>+</sup>CD62L<sup>-</sup>) T cells, <bold>(G)</bold> AMs, <bold>(H)</bold> DCs, <bold>(I)</bold> Non-alveolar macrophages, <bold>(J)</bold> neutrophils, <bold>(K)</bold> Mtb<sup>+</sup> neutrophils and Mtb burden (based on MFI of GFP) in Mtb-infected neutrophils, and <bold>(L)</bold> Mtb<sup>+</sup> AMs in the lung at 21dpi. <bold>(M)</bold> Mtb CFU count in the lung at 21dpi. Each data point corresponds to one mouse and graphs show the mean ± SEM, where in <bold>(E-L)</bold> the data are expressed as the ratio to the average for WT mice. Statistical significance of differences was determined by one-way ANOVA’s Tukey’s multiple comparison test and only significant comparisons are shown. **** P &lt; 0.0001; *** P &lt; 0.001; ** P &lt; 0.01; * P &lt; 0.05.</p></caption><graphic xlink:href="EMS189197-f004"/></fig><fig id="F5" position="float"><label>Fig. 5</label><caption><title>Increased type I IFN signaling in <italic>Irgm1</italic><sup>-/-</sup> mice during Mtb infection is dependent on IRGM3 expression</title><p><bold>(A)</bold> Mtb CFU count in lungs at 21 dpi. The legend in <bold>(A)</bold> applies to all subsequent panels. <bold>(B)</bold> Survival of mice following Mtb infection (WT n=3, <italic>Irgm1</italic><sup>-/-</sup> n=2, <italic>Irgm1<sup>-/-</sup>/Irgm3<sup>-/-</sup></italic> n=8 and <italic>Irgm3<sup>-/-</sup></italic> n=8). Statistical significance of differences in survival compared to <italic>Irgm1</italic><sup>-/-</sup> mice determined by Mantel-Cox test. <bold>(C)</bold> qRT-PCR analysis of ISG expression in lungs at 21 dpi. <bold>(D-E)</bold> Number of activated CD4<sup>+</sup> T cells (CD44<sup>+</sup>) in <bold>(D)</bold> dLN and <bold>(E)</bold> lungs at 21dpi. <bold>(F-G)</bold> Number of DCs in <bold>(F)</bold> dLN and <bold>(G)</bold> lungs at 21dpi. <bold>(H-I)</bold> Number of <bold>(H)</bold> Mtb<sup>+</sup> neutrophils and Mtb burden (based on MFI of GFP) in Mtb infected neutrophils and <bold>(I)</bold> Mtb<sup>+</sup> AMs in the lung at 21dpi. Each data point corresponds to one mouse and graphs show the mean ± SEM, where in <bold>(D-I)</bold> the data are expressed as the ratio to the average for WT mice. Statistical significance of differences was determined by one-way ANOVA’s Tukey’s multiple comparison test and only significant comparisons are shown. **** P &lt; 0.0001; *** P &lt; 0.001; ** P &lt; 0.01; * P &lt; 0.05.</p></caption><graphic xlink:href="EMS189197-f005"/></fig><fig id="F6" position="float"><label>Fig. 6</label><caption><title>Model of IRGM1-mediated control of Mtb pathogenesis</title><p>Schematic diagram of model where IRGM1 is required to suppress IRGM3-mediated induction of type I in naïve mice. Following Mtb infection, the higher levels of type I IFN sensitize activated T cells to IFN-g-stimulated cell death, precluding T<sub>H</sub>1 CD4<sup>+</sup> T cell expansion. In addition, the heightened type I IFN signaling leads to decreased numbers of DCs in the lungs and dLN during Mtb infection, which may also negatively impact the initiation of T<sub>H</sub>1 responses. Loss of T<sub>H</sub>1 CD4<sup>+</sup> T cell expansion results in uncontrolled Mtb infection and replication in neutrophils and AMs, causing the mice to succumb to the infection.</p></caption><graphic xlink:href="EMS189197-f006"/></fig></floats-group></article>